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Antibiotics and antibiotic resistance determinants, natural molecules closely related to
bacterial physiology and consistent with an ancient origin, are not only present in antibiotic-
producing bacteria. Throughput sequencing technologies have revealed an unexpected
reservoir of antibiotic resistance in the environment. These data suggest that co-evolution
between antibiotic and antibiotic resistance genes has occurred since the beginning of
time.This evolutionary race has probably been slow because of highly regulated processes
and low antibiotic concentrations. Therefore to understand this global problem, a new
variable must be introduced, that the antibiotic resistance is a natural event, inherent to
life. However, the industrial production of natural and synthetic antibiotics has dramatically
accelerated this race, selecting some of the many resistance genes present in nature and
contributing to their diversiﬁcation. One of the best models available to understand the
biological impact of selection and diversiﬁcation are β-lactamases.They constitute the most
widespread mechanism of resistance, at least among pathogenic bacteria, with more than
1000 enzymes identiﬁed in the literature. In the last years, there has been growing concern
about the description, spread, and diversiﬁcation of β-lactamases with carbapenemase
activity and AmpC-type in plasmids. Phylogenies of these enzymes help the understanding
of the evolutionary forces driving their selection. Moreover, understanding the adaptive
potential of β-lactamases contribute to exploration the evolutionary antagonists trajectories
through the design of more efﬁcient synthetic molecules. In this review, we attempt to
analyze the antibiotic resistance problem from intrinsic and environmental resistomes
to the adaptive potential of resistance genes and the driving forces involved in their
diversiﬁcation, in order to provide a global perspective of the resistance problem.
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INTRODUCTION
Nowadays and thanks to the high-throughput sequencing tools
and bioinformatics software, knowledge on high bacterial diver-
sity in bacterial communities (metagenome) is increasing. A huge
diversity of resistance mechanisms to practically all antibiotic
families has been found in both antibiotic- and non-antibiotic-
producing bacteria (D’Costa et al., 2006; Bhullar et al., 2012).
Three types of resistome can be deﬁned: intrinsic, environmen-
tal, and unknown (Fajardo et al., 2008; Martínez, 2008; Dantas
and Sommer, 2012). In the intrinsic resistome or pre-resistome,
the antibiotic resistant elements belong to bacterial metabolic net-
works, reﬂecting their role in microbial physiology. They might
be coupled to signaling molecules (antibiotics) facilitating the
co-selection of antibiotics and antibiotic resistance genes in a
constant arms-race over a long time (Fajardo and Martínez, 2008).
So today the intrinsic resistome is a wider concept and prob-
ably universal to the bacterial world. The description of the
intrinsic resistome has expanded our knowledge about poten-
tial new resistance mechanisms (Dantas et al., 2008; Toleman
et al., 2012). They could become true antibiotic resistance genes if
appropriate driving forces were exerted. Moreover, the potential
adaptiveness of these pre-resistome genes can be accelerated if, by
chance, they are transferred to new genetic contexts (exaptation;
Figure 1), where these genes may evolve toward more efﬁcient
enzymes without having a physiological role (Baquero et al., 2009;
Gullberg et al., 2011). As a consequence, this silent and non-
predictive resistome (unknown resistome) is ready to be selected
(Baquero, 2012).
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FIGURE 1 | Overview evolutionary processes of the antibiotic
resistance. During millions of years antibiotics and antibiotic resistance
genes have co-evolved slowly. In this long period the ﬁrst transition
was the acquisition of pre-resistance genes by different bacteria
(exaptation). This genetic transference allowed the evolution toward
true and more efﬁcient antibiotic resistance genes. However, the
great evolutionary transition was the discovery, mass production and
consumption of antibiotics. Antibiotics accelerated dramatically the
diversiﬁcation of resistance genes and selection for reaching extraordinary
efﬁcient variants.
Efforts to understand the spread of antibiotic resistance and
ﬁnd previously undescribed antibiotic resistance mechanisms in
non-human environments have yielded a more complex view of
the antibiotic resistance problem (D’Costa et al., 2006; Dantas
et al., 2008; Bhullar et al., 2012). Usually, the bacterial population-
nutrient concentration ratio is low in the environment and amodel
of competitive interactions among microorganisms is established.
Microbial competitors are able to produce high levels of natural
antibiotics that become toxic compounds killing non-producer
competitor strains in order to access the limited nutrients. How-
ever, antibiotic susceptible strains were able to develop strategies
conferring resistance to these antibiotics, constituting the environ-
mental resistome, starting adaptation, and co-adaptation cycles
between antibiotics and antibiotic-resistant proteins (Martínez,
2009). New sequencing platforms have revealed that our old
concept that only the antibiotic-producing bacteria were carri-
ers of antibiotic resistance mechanisms was a very simple view.
The scientiﬁc community has gradually begun to understand that
antibiotic resistance has a global distribution in nature, even with-
out the presence of humans, and that antibiotics and antibiotic
resistance mechanisms have been evolving for millions of years
(Wright, 2010).
The capture of antibiotic resistanceorpre-resistance genes from
intrinsic, environmental, or unknown resistomes is a stochastic,
unpredictable phenomenon. Once the determinants of resistance
reach the human environments or environments related to human
activity, the evolutionary race between antibiotics and antibiotic
resistance genes is drastically accelerated, as a consequence of the
high concentration of antibiotics (Martínez et al., 2007). There-
fore, antibiotics are not only selector agents of mechanisms of
resistance; they are also accelerator agents of the evolution of
resistance (Figure 1). This is a consequence of the huge plas-
ticity observed in antibiotic resistance genes for acquiring a new
spectrum of action or more efﬁcient capacities with respect to the
original spectrum (Deng et al., 2012). This observation suggests
that the diversiﬁcation force of resistance elements can be as fast
and strong as the antibiotic diversiﬁcation. For instance, the golden
age in the commercialization for clinical use of β-lactamantibiotics
was between the late 1970s and mid 1980s. Based on dated phy-
logenetic reconstructions of the most important β-lactamases in
the clinical setting, the majority of diversiﬁcation events occurred
recently, even though the enzymes have been present for millions
of years (Barlow and Hall, 2002a,b). In vitro models with CTX-M
β-lactamases suggest that the explosivemolecular diversiﬁcationof
these enzymes could only be explained by the simultaneous pres-
ence of different extended spectrum cephalosporins (Novais et al.,
2010). Similar results were found with TEM enzymes (Salverda
et al., 2011), suggesting that both the environmental contamina-
tion with different β-lactams and the potential plasticity of these
enzymes could have been the main diversifying forces. Tradition-
ally, the problem of antibiotic resistance has been focused as a
clinical problem. Obviously, human health is the main reason,
but we will never be able to cope with the antibiotic resistance
problem if it is only seen as such. In this review, we attempt
to analyze the antibiotic resistance problem from new perspec-
tives. From the intrinsic resistome to the potential adaptiveness
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of determinants of resistance, from the environmental resistome
to the driving forces involved in the diversity of variants related
to speciﬁc determinants of resistance, as well as to provide a
global view of the antibiotic resistance problem (Davies, 2007;
Martínez et al., 2009).
INTRINSIC RESISTANCE OR INTRINSIC RESISTOME
In the EUCAST expert rules on antimicrobial susceptibility testing,
“intrinsic resistance”or“inherent resistance”is understoodas a fea-
ture of all or almost all isolates of a bacterial species and in contrast
to the acquired and/or mutational resistance concepts (Leclercq
et al., 2011). From a microbiological point of view, intrinsic resis-
tance can be a result of: (i) inherent difﬁculties for the antibiotic
to reach its corresponding target due to impaired permeability of
the bacterial envelope or efﬁcient drug export systems, the so-
called multi-drug resistance (MDR) efﬂux pumps; (ii) the absence
of antimicrobial target(s) or presence of targets with low afﬁn-
ity; or even (iii) the presence of a mechanism that inhibits or
destroys the antibiotics (enzymes that neutralize antibiotics in the
cytoplasm or periplasmic space). Some examples of these mech-
anisms are included in Table 1. Nevertheless, all microorganisms
contain efﬂux pumps involved in bacterial physiology, which can
participate in resistance to different extents, although the clini-
cal consequences might be of minor importance unless coupled
with other resistance mechanisms (Li et al., 1994a,b; Piddock,
2006; Martínez, 2012; Nessar et al., 2012). Often, bacteria com-
bine different mechanisms affecting several antimicrobial drugs.
Conventionally, the intrinsic resistome has been deﬁned as the set
of chromosomal genes that are involved in intrinsic resistance and
whose presence in strains of a bacterial species is independent of
previous antibiotic exposure and is not due to horizontal gene
transfer (Martínez, 2012).
Nowadays, the “intrinsic resistome” is a wider concept than
intrinsic resistance and includes genetic elements normally
belonging to bacterial metabolic networks that can eventually par-
ticipate in resistance to antimicrobial agents. Pre-resistance genes
constituting the intrinsic resistome has two main characteristics:
ﬁrstly, they confer low level of resistance which is also known as
“pre-resistome” (Fajardo et al., 2008); secondly, the different resis-
tance mechanisms are expressed at low levels, but their expression
can increase due to the involvement of regulatory genes or as a
consequence of mutational events, the so called “silent resistome”
(Dantas and Sommer, 2012). Global transcriptome analyses of
microorganisms grown in the presence of β-lactams induce the
expression of ampC (Bagge et al., 2004). This chromosomal gene,
present in the genome of Pseudomonas aeruginosa and of many
Enterobacteriaceae for several hundred millions of years, plays a
physiological role in the normal course of peptidoglycan synthe-
sis, remodeling and recycling the bacterial envelope (Jacobs et al.,
1994; Henderson et al., 1997).
For years recognition of the intrinsic resistome has not been
an easy task. This will not be the case in the coming years as
the implementation of whole genome sequencing strategies and
bioinformatic tools for genome comparisons and knockout pro-
cedures will increase the recognition of determinants that might
be involved in resistance phenotypes, even if they are very lowly
expressed (Didelot et al., 2012; Huang et al., 2012; Schmieder
and Edwards, 2012). The increased expression of these systems
increases resistance levels (increased MIC values) whereas their
absence increases bacterial susceptibility (decreased MIC values;
Alekshun and Levy, 2007).
Hence, in bacterial resistance the differentiation between
intrinsic resistome and intrinsic resistance is a thin line, but low-
level resistance can be associated at a certain point to intrinsic
resistome and high-level resistance to intrinsic resistance (Leclercq
et al., 2011).
ANTIBIOTICS AND ANTIBIOTIC RESISTANCE GENES HAVE
ANCIENT ORIGINS
During the 1970s, it was shown that resistance genes related to
aminoglycoside modifying enzymes (AMEs) in clinical bacteria
had their origin in common soil bacteria belonging to Acti-
nomycetes, which also produce AMEs (Benveniste and Davies,
1973). However, metagenome studies from different sources have
questioned the “hypothesis of the antibiotic producers” because
antibiotic resistance genes have been found in the microbiome of
ancient isolated environments datingback amillion years (D’Costa
et al., 2006; Allen et al., 2010; Torres-Cortés et al., 2011; Bhullar
et al., 2012). The functional role of antibiotic resistance genes in
antibiotic-producing bacteria seems clear: they need to protect
themselves from the activity of their own antimicrobials; however,
in non-producers their role is less evident. Some explanations
have been suggested. First, antibiotic resistance genes have or have
had a physiological role in bacteria (see below). Second, antimi-
crobial agents are more prevalent than suspected. Analyses of
bacterial genome sequences suggest that only 10% of the natural
antibiotics have been discovered and probably only 1% of antimi-
crobial molecules from producers are known (Fischbach, 2009),
possibly because they are natural products of bacterial physiol-
ogy (Osbourn, 2010). More probably both scenarios are true and
non-exclusionary. The complex network of physiological interac-
tions that constitute the intrinsic resistome is coupled to small
natural molecules, such as antibiotics, which might have a role
as signaling molecules. According to this concept, antibiotics and
Table 1 | Different examples of intrinsic resistance with clinical relevance.
Intrinsic resistance
mechanisms class
Resistance mechanism Antibiotics affected Microorganisms
Inadequate target PBP5 mutations Cephalosporins Enterococcus faecium
Inactivating process L1 beta-lactamase Carbapenems Stenotrophomonas maltophilia
Impaired permeability Impermeable cell barrier Vancomycin Enterobacteriaceae
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antibiotic resistance genes have evolved duringmillions of years by
forming interactions in coupled bacterial-speciﬁc networks, both
by the same and different species (Arifuzzaman et al., 2006). For
instance, different Staphylococcus aureus strains synthesize pep-
tides that are recognized as signals by strains belonging to the
same group and are competitive inhibitors against other S. aureus
strains belonging to different lineages (Ji et al., 1997).
An accepted hypothesis is that these low molecular weight nat-
ural products (antibiotics) could originally be signaling molecules
that help shaping the structure of microbial communities (Yim
et al., 2007; Linares et al., 2006; Fajardo and Martínez, 2008). Even
quinolone compound derivatives, which are produced by a vari-
ety of plants and microorganisms, have been found to act as
quorum-sensing signal molecules, controlling the expression of
virulence genes as a function of cell population density. This has
been particularly investigated in P. aeruginosa. In this species, these
compounds play multiple roles as membrane-interacting com-
pounds, inhibitors of cytochrome complexes and iron chelators, as
well as in the regulation of their biosynthesis and their integration
into the intricate quorum-sensing regulatory networks governing
virulence and secondary metabolite gene expression (Heeb et al.,
2011). This could also be the case of other antibiotics, includ-
ing small peptide molecules that might have a potential role in
complex bacterial communities (microbiomes; Belda-Ferre et al.,
2012). Therefore, the production of antibiotics is under strict
genetic control. In resource-limited environments or when bacte-
rial cells reach the stationary phase, the production of microbial
secondary metabolites, such as microcins, is increased in order to
yield a survival advantage to the producing bacteria (Romero et al.,
2011). Microcins are DNA-damaging agents and, in consequence,
the SOS regulon is induced and the chromosomal gene encod-
ing the physiological inhibitor DNA gyrase, gyrI, is over-expressed
(Baquero et al., 1995). This case is one of the examples showing
that antibiotics and antibiotic resistance genes are natural products
in constant and ancestral co-evolution (Chatterji and Nagaraja,
2002). Another interesting example is that of β-lactamases, which
are structurally similar to PBPs (penicillin-binding proteins),
the target of β-lactam antibiotics, the enzymes involved in the
metabolism of peptidoglycan (Massova and Mobashery, 1998).
Some PBPs such as PBP5 have weak β-lactamase activity confer-
ring a low β-lactam resistance phenotype (Sarkar et al., 2011). In
conclusion, antibiotics and also antibiotic resistance genes might
have a dual functional and ecological role. At low concentrations
antibiotics are signaling systems and at high concentrations they
are weapons (Fajardo and Martínez, 2008).
PHYSIOLOGICAL ROLE OF THE INTRINSIC RESISTOME
ELEMENTS AND THE UNKNOWN OR SILENT RESISTOME
It has been anticipated that the intrinsic resistome elements have
a physiological role in bacteria other than conferring resistance to
antibiotics currently used in the clinical practice (Wright, 2007,
2010). A recent review addressing the importance of Mycobac-
terium abscessus, a rapidly growing bacteria involved in soft-tissue
infections and chronic pulmonary diseases, showed the presence
of a high number of resistancemechanisms responsible for natural
resistance in this species, including efﬂux pumps, antibiotic-
modifying enzymes, and target-modifying enzymes (Nessar et al.,
2012). Most of these genes have physiological functions but
express resistance in the presence of antibiotics, again suggesting
that antibiotic resistance genes are the result of speciﬁc adaptive
responses in genes with previous physiological roles.
The idea that intrinsic resistance is a consequence of the global
bacterial physiology was later demonstrated with the study of
the intrinsic resistomes of P. aeruginosa (Fajardo et al., 2008) and
Escherichia coli (Tamae et al., 2008). P. aeruginosa is thought to be
intrinsically resistant to several antimicrobial agents mainly due
to a reduced cellular permeability and the activity of MDR efﬂux
pumps. Fajardo et al. (2008) performed a transposon-tagging
experiment to determine the elements involved in the intrinsic
resistance of P. aeruginosa. They demonstrated that ∼2% of the P.
aeruginosa genome is involved in the altered susceptibility against
different categories of antibiotics, but surprisingly only one gene
had been annotated as an antibiotic resistance gene (Fajardo et al.,
2008). Many of the genes detected as related to antibiotic resis-
tance are involved in basic bacterial metabolism. However, their
phenotypic effect is weak; therefore, the development of a real
intrinsic resistance phenotype requires a complex assemblage of
mutations, such as those previously commented in efﬂux pumps.
Those genes with a physiological function in the bacteria rep-
resenting genes that do not confer clinical resistance to their native
host, but are capable of expressing resistancewhen up-regulated or
expressed in other hosts (exaptation) can eventually be involved
in resistance will be part of the so-called “unknown resistome.”
Elements from the intrinsic resistome and the unknown resis-
tome have been stressed as potential targets for the design of new
interventions to prevent antimicrobial resistance (Martínez,2012).
THE ENVIRONMENTAL RESISTOME
Although the origin of antibiotic resistance was mysterious in the
past, it has become evident over the last decade that environmental
bacteria were highly resistant to antibiotics (Wright, 2010). In fact
this was discovered 40 years ago by Benveniste and Davies (1973)
who found that AMEs from various species of the genus Strepto-
myces were similar to those found in clinical bacteria. Similarly,
resistance to vancomycin, ﬁrst reported in 1988 in Enterococcus
faecium clinical isolates in Europe (Leclercq et al., 1988), was later
found to be associated with glycopeptide antibiotic-producing
Actinomycetes from soil (Marshall et al., 1997, 1998) as well as
in non-antibiotic-producing bacteria of the genera Paenibacil-
lus and Rhodococcus from soil (Guardabassi et al., 2004). More
recently it has been demonstrated that several antibiotic resistance
genes (genes conferring resistance to β-lactams, aminoglycosides,
tetracyclines, sulfonamides, and phenicoles) have been exchanged
between environmental bacteria and clinical pathogens on the
basis of perfect nucleotide sequence identities of these genes with
those from diverse human pathogens (Forsberg et al., 2012). In
2010, Knapp et al. (2010) quantitatively analyzed the abundance
of 18 antibiotic resistance genes from ﬁve long-term-soil extracted
DNAs from different areas in The Netherlands covering the years
1940 to 2008. They found that antibiotic resistance genes from
all classes of antibiotics have increased since 1940, especially for
tetracycline and β-lactam resistance encoding genes that have a
higher abundance in the twenty-ﬁrst century when compared
with the 1970s, suggesting that levels of antibiotic resistance genes
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in the environment are now high and increasing (Knapp et al.,
2010). Although resistant organisms in the environment may be
the result of contamination by the recent use and misuse of antibi-
otics by humans, this previous dogma is now seriously disputed
thanks again to the advances in new high throughput sequencing
technologies (Rolain et al., 2012).
Aquatic environments are also a source for antibiotic resis-
tance genes. The bacteria and/or antibiotic resistance genes could
be transmitted directly or indirectly from these environments to
humans (Zhang et al., 2009) as result of contamination by the
recent use of antibiotics in agriculture and aquaculture selecting
these intrinsic resistance genes (Baquero et al., 2008; Zhang et al.,
2009; Wright, 2010). Many different antibiotic resistance genes
from different classes of antibiotics (tetracyclines, aminoglyco-
sides, macrolides, chloramphenicol, vancomycin, sulfonamides,
and β-lactams) have been detected in different water environ-
mentsworldwide using differentmolecular techniques as reviewed
recently (Baquero et al., 2008; Zhang et al., 2009). The recent
emergence and spread of carbapenemase encoding genes inGram-
negative bacteria seems to have originated from bacterial species
in water environments (Lupo et al., 2012). For example, par-
tial OXA-23 like carbapenemase sequences have been detected in
groundwater samples from the KatmanduValley of Nepal (Tanaka
et al., 2012) that were 100% similar to those of sequences found
in human head lice from Senegal (Kempf et al., 2012), suggest-
ing that arthropods may also be a source of antibiotic resistance
genes in human pathogens. Recently, MDR E. coli and Klebsiella
spp. with extended spectrum β-lactamase (ESBLs) have been cul-
tured from municipal wastewater treatment plant efﬂuents in the
Czech Republic (Dolejska et al., 2011). Similarly, several bacterial
species including humanpathogens carryingNDM-1, recently dis-
covered (Yong et al., 2009) and spreading worldwide (Rolain et al.,
2010), have been detected in tap and drinking water as well as
drain and sewage in India (Walsh et al., 2011; Shahid et al., 2012)
and in seepage water (rivers, lakes, and water pools in streets)
from Vietnam (Isozumi et al., 2012). These data implicate con-
taminated aquatic environments, as a likely site for the exchange of
antibiotic resistance genes between the clinic and the environment
(Baquero et al., 2008).
Wild animals and pets, especially their gut microbiota,may also
be a source for antibiotic resistance genes that come in contactwith
humans (Allen et al., 2010). Pets, cats and dogs in particular, may
be a source for antibiotic resistance genes that could be transmitted
to humans and the environment and vice versa (Guardabassi et al.,
2004). It has been shown that resistance to antibiotics in bacteria
recovered from pets has increased markedly over the last decade,
especially the emergence of MDR Acinetobacter baumannii, E. coli,
Salmonella enterica, Staphylococcus intermedius, or methicillin-
resistant S. aureus that could be a risk for transmission to humans
(Lloyd, 2007). Gilliver et al. (1999) reported more than 10 years
ago that antibiotic resistance was highly prevalent even in wild
rodents that were believed not to be exposed to antibiotics. Sim-
ilarly, vancomycin-resistant enterococci carrying the vanA gene
have been isolated from feces of wild mammals in the United
Kingdom (Mallon et al., 2002), OXA-23 carbapenemase encoding
gene in Acinetobacter species from the gut microbiota of cattle in
France (Poirel et al., 2012), or MDR E. coli in European wild boars
(Poeta et al., 2009; Literak et al., 2010), pigs, and rodents (Literak
et al., 2009). Wild birds may also be a source for antibiotic resis-
tance genes and their dissemination by migratory birds, as recently
exempliﬁed using functional metagenomics of a huge diversity of
antibiotic resistance genes in fecal samples from a breeding colony
of gulls in the United States (Martiny et al., 2011) or ESBL E. coli
in great cormorans and mallards in Europe (Tausova et al., 2012).
Finally, it has been recently shown that feces from urban pigeons
in Brazil contain MDR enterococci (da Silva et al., 2012). Similarly,
MDR enterococci including Enterococcus faecalis and Enterococcus
gallinarum isolates resistant to vancomycin and MDR E. coli have
been recovered from feces of feral pigeons in the Czech Republic
(Radimersky et al., 2010), suggesting that pigeons should be con-
sidered a risk species thatmay contribute to the spreadof resistance
in the urban environment.
In recent years, new technological approaches, especially
functionalmetagenomics, have led to the characterization and dis-
covery of many unknown antibiotic resistance genes, the so-called
resistome, i.e., all antibiotic resistance genes at a global scale in
any bacteria (Wright, 2007). Functional metagenomic approaches
have been developed and used to decipher the resistome in soil
samples by Handelsman (2004) in 2004 that led to the discovery
of new antibiotic resistance genes such as AMEs and β-lactamases.
The ﬁrst study of the extent of this resistome was reported by
D’Costa et al. (2006) from bacteria isolated from soils showing
that many environmental bacteria were MDR and that half of
the antibiotic resistance genes discovered were unknown. More-
over, novel mechanisms of resistance involving the inactivation
of telithromycin and daptomycin, two antibiotics approved in the
last decade were discovered thanks to this approach (D’Costa et al.,
2006). Later, Dantas et al. (2008) conﬁrmed the presence of bac-
teria from soils intrinsically resistant to many different classes of
antibiotics.
Nowadays, there is evidence that these antibiotic resistance
genes have an ancient origin as demonstrated by the recent
discovery using metagenomic analysis of genes conferring resis-
tance to β-lactams, tetracyclines, and glycopeptides in permafrost
sediments dating from30,000 years ago (D’Costa et al., 2011). Sim-
ilarly, MDR bacteria have been recently cultured from soil samples
of an over 4 million year old cave in New Mexico (Bhullar et al.,
2012), revealing an unexpected reservoir of antibiotic resistance
genes in the environment. Although environmental reservoirs are
well known as a possible source of antibiotic resistance genes
detected in human pathogens, reports of antibiotic resistance
genes from environmental bacteria with a high level of sequence
similarity to those from human pathogens previously reported are
limited. CTX-M-8 β-lactamase in environmental bacteria of the
genus Kluyvera (Poirel et al., 2002) or qnrA-like genes from marine
and freshwater bacteria of the genus Shewanella (Poirel et al., 2005)
are examples of antibiotic resistance transferred from environ-
mental bacteria to human pathogens. But, the environmental
resistome is not only a huge reservoir of antibiotic resistance genes;
it is also a generator of new mechanisms of resistance. The ﬁnding
of a new bifunctional β-lactamase in a remote Alaskan soil sam-
ple (Allen et al., 2009) or the chimeric origin of the New Delhi
metallo-β-lactamase NDM as the consequence of a recombina-
tion event between AME and β-lactamase (Toleman et al., 2012)
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are good examples of new antibiotic resistance arising in the
environment.
In summary, antibiotic resistance is a natural and ancient phe-
nomenon and its recent increase of antibiotic resistance among
pathogenic bacteria has been the result of the ancient and recent
mobilization of resistance genes from these environmental and
animal reservoirs to human pathogens. Nevertheless, in spite of
the efforts to clearly identify transfer events from environmental
to pathogenic strains, only a few examples have been documented.
The paucity of genetic evidence to date this transference is more
likely the consequence of under sampling rather than that these
exchanges have not occurred. Our knowledge of the environmen-
tal resistome remains low and future studies should be focused on
discovery of these new antibiotic resistance genes for the better
understanding of the magnitude of this phenomenon in environ-
mental reservoirs and its potential impact in human pathogens.
Another reason for the few cases documented so far could be
related to the complex interplay between resistome genotypes
and resistance phenotypes, which could be context-depend. Only
some speciﬁc genetic combinations of resistance genes, plasmids,
strains, and microbial community can be successful. Therefore,
in the absence of experimental evidence the spectrum of action
will be difﬁcult to assess (Dantas and Sommer, 2012). The high
prevalence and diversity of both antibiotic resistance genes and
bacterial species in the environment make these ecosystems an
opportunity to decipher the mechanisms of transfer and usage of
these genes in bacteria living in a sympatric lifestyle which is a key
component for bacterial evolution (Diene et al., 2012). We need
to understand the magnitude of this phenomenon in the future
in order to be able to deﬁne new strategies to face the problem of
antibiotic resistance globally and not only from a human medical
viewpoint.
MOBILIZATION AND EXPRESSION OF INTRINSIC RESISTOME
ELEMENTS
Comparisons of soil microbiota with clinical pathogens have pro-
vided evidence of an ancient and recent exchange of antibiotic
resistance genes (β-lactams, aminoglycosides, amphenicols, sul-
fonamides, and tetracyclines) as well as the multiple mobilizations
of sequences between these communities. They demonstrate not
only evidence of lateral exchange but also a mechanism for the
dissemination of antibiotic resistance (Forsberg et al., 2012). If
the assumption that the intrinsic resistance has an ancient origin
in environmental genes, then it can also be accepted that these
genes are transmitted to human pathogenic bacteria. Admittedly
these genes could be mobilized from their ancestors. Among these
intrinsic resistance genes, β-lactamases genes (bla genes) are con-
sidered one of the best examples and are also discussed in this
review.
As previously commented, amino acid sequence analysis of
PBPs and β-lactamases point to a common origin of these proteins
(Bush, 1997; Massova and Mobashery, 1998). Nevertheless, dif-
ferent ancestors have been recognized and different evolutionary
trajectories might have occurred (Cantón, 2007). The analysis of
β-lactamase phylogeny is not congruent with the phylogenetic his-
tory of its carriers, as horizontal gene transfer, frequently produced
over time, might have interfered in the evolutionary process of
β-lactamases. In some cases, such as class D (OXA type) enzymes,
they are present both in Gram-positive and Gram-negative bac-
teria whereas Class C enzymes are only present in Gram-negative
organisms (unlike Mycobacterium smegmatis), reﬂecting different
evolutionary trajectories. Along these trajectories, β-lactamases
have had to undergo structural alterations to become efﬁcient as
β-lactam-hydrolyzing enzymes, avoiding the interactionwith pep-
tidoglycan (or peptidoglycan precursors), which are the substrates
of PBPs. It has been hypothesized that this gives an advantage to
β-lactamase-producing bacteria, particularly in soil communities,
where natural β-lactam-producing bacteria might be normally
present (Bush, 1997).
One of the most studied β-lactamases is the Class A enzymes.
Within this group the most widely distributed enzyme is TEM-
1, which was ﬁrst described in 1963 (Datta and Kontomichalou,
1965). The bla gene encoding this enzyme is carried in a
transposable element (Tn3) that is widely present in plasmids
of different incompatibility groups (Hedges and Jacob, 1974).
Despite its widespread presence all over the world and in many
different pathogenic bacteria, including among others all Enter-
obacteriaceae, Haemophilus inﬂuenzae, Neisseria gonorrhoeae,
and P. aeruginosa, its ancestor remains undetermined. This is
not the case of the CTX-M enzymes, which were recognized
as plasmid-mediated enzymes hydrolyzing extended-spectrum
cephalosporins (i.e., cefotaxime) in 1989 (Bauernfeind et al.,
1990), from environmental bacteria of the genus Kluyvera (Poirel
et al., 2002).
Nowadays, the CTX-M enzymes are widely disseminated all
over the world within Enterobacteriaceae (Cantón and Coque,
2006). The corresponding genes, the blaCTX−M, have been found
in chromosomal location in different species of the genusKluyvera,
which is generally accepted as the origin of these genes (Can-
tón et al., 2012). In the Kluyvera species, cefotaxime resistance
has low levels of expression. Mobilization by insertion sequences
(IS), such as ISEcp1 or ISCR1, has resulted in higher expression
of resistance in E. coli, K. pneumoniae, and other clinically rele-
vant Enterobacteriaceae (Poirel et al., 2003; Lartigue et al., 2006;
Rodriguez-Martinez et al., 2006).
Similar to Class A enzymes, the mobilization of blaOXA genes
has been estimated to have occurred at different times, the ﬁrst
one a hundred million years ago, whereas the last mobilization
occurred very recently. This could have been the case of the
carbapenem-hydrolyzing β-lactamase OXA-48 and its derivative
OXA-181, which differs from the former by four amino acid
substitutions, which have been related with Shewanella xiame-
nensis (Potron et al., 2011). This is an environmental species
from marine and freshwaters that contains the blaOXA−181 gene.
OXA-48-producing Enterobacteriaceae are increasingly recog-
nized worldwide whereas the detection of OXA-181-producing
isolates remains scarce (Poirel et al., 2012). Similarly to some of
the blaCTX−M genes, the blaOXA−181 gene was also preceded by
its insertion in the element ISEcp1, which might also have been
responsible for its mobilization.
Interestingly, other species from Shewanella might also play an
important role as the origin and reservoirs of resistance deter-
minants. They have been found to harbor not only different β-
lactamases genes but also resistance genes affecting other antibiotic
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classes such as ﬂuoroquinolones (qnrA gene in Shewanella algae;
Poirel et al., 2005; Rodriguez-Martinez et al., 2005). In the case
of β-lactamases, Shewanella oneidensis and Shewanella algae har-
bor chromosomal class D β-lactamases genes (blaOXA−54 and
blaOXA−55, respectively) and Shewanella livingstonensis and She-
wanella frigidimarina harbor chromosomal metallo-β-lactamase
genes (blaSLB−1 and blaSFB−1, respectively; Poirel et al., 2005).
None of these genes has been found yet in plasmids but they could
eventually be mobilized to pathogenic bacteria. Unlike these cases,
the blaOXA−23 gene, whose progenitor has been found in Acineto-
bacter radioresistens, is nowadays widely spread in A. baumannii
(Walsh, 2008).
All these examples illustrate how the intrinsic resistome can
be mobilized from environmental bacteria and expressed at dif-
ferent levels in new hosts. However, it is surprising that despite
the huge environmental and intrinsic resistome in environmental
and commensal bacteria we can identify transmission events in
only a few cases (Table 2; Davies, 1997; Davies and Davies, 2010),
suggesting the existence of biochemical, metabolic, and genetic
constrictions (Dantas and Sommer, 2012). When we are capable
of understanding the “global resistome,” i.e., the environmental
and intrinsic (including silent) resistome, then all the bacterial
potential for ﬁghting other bacteria will be known and only then
will we be able to ﬁght the antibiotic war on equal terms. Then, the
following steps in our understanding of the resistance process will
be to deﬁne and reveal the adaptive potential of those physiological
genes that evolved toward resistance genes.
PHYLOGENY AND EVOLUTION OF β-LACTAMASES
Antibiotic resistance is probably one of the best examples of “evo-
lution in action.” The basic mechanisms of resistance appeared
early in the evolutionary time-scale and evolved to counter the
new defenses put forward by other bacterial species to compete for
resources or survival against competitors and predators (Baquero
and Blázquez, 1997; Salmond andWelch, 2008; Davies and Davies,
2010). It has been commented several times throughout this
review that antibiotic resistance genes were ancient elements with
a physiological role as components of complex networks. The
decontextualization of these genes from their original background
(exaptation) allowed a slightly faster evolutionary process toward
a real antibiotic resistance per se. However, it is certain that since
the adoption of antibiotic therapy to combat infectious diseases in
the mid-twentieth century, the pace of this evolutionary race has
accelerated tremendously. The most relevant player in this game
is natural selection, which results from the advantage gained by a
mutant organism that can overcome more efﬁciently the deleteri-
ous effects of antibiotics, and also by antibiotic-producers, which
are able to ﬁnd a new way of evading these defenses. In fact,
this important role of natural selection has been demonstrated
at different scales, from the observed changes in the prevalence of
antibiotic resistance genes to the molecular level, by identiﬁcation
of those amino acid residues that are the main targets of selection
(Novais et al., 2010).
Notwithstanding the relevance of natural selection, other
evolutionary mechanisms are also important in the evolution
of antibiotic resistance. Obviously, the most important chance
involved in evolutionary success is related to horizontal gene trans-
fer and the integration of antibiotic resistance gene in widespread
plasmids and/or clones, but this aspect is not considered in this
review. Other chance events such as mutations may play an impor-
tant role in the evolutionary trajectories followed by antibiotic
resistance strains. This has been experimentally shown to occur in
the evolution of resistance to β-lactams on at least two occasions.
Novais et al. (2010) showed that depending on the ﬁrst mutation
to appear in a few critical positions, resistance to cefotaxime and
ceftazidime might follow-up to three alternative routes in CTX-
M-type β-lactamases. A similar result was obtained after the in
vitro evolution of TEM-1 β-lactamase (Salverda et al., 2011).
Apart from contingency, other stochastic processes may also be
important for the evolution of antibiotic resistance. In their anal-
ysis of CTX-M experimental evolution, Novais et al. (2010) found
that Darwinian selection alone could not explain the evolution
of the CTX-M variants with the highest resistance to cefotaxime
and ceftazidime because the ﬁtness gradient along the different
alternative routes always involved at least some steps of reduced
ﬁtness. The alternative possibility discussed byNovais et al. implies
the action of genetic drift and selection in heterogeneous environ-
ments to cross these ﬁtness valleys. In consequence, the action of
natural selection does not guarantee, on its own, the evolution
of the genotype with the highest ﬁtness. Therefore, it would be of
interest to extend these analyses to other antibiotic resistance genes
and to evaluate the prevalence and relevance of natural selection
and other evolutionary mechanisms in their recent and ancient
evolution.
Table 2 | Examples of resistance mechanisms in clinical isolates that evolved from natural functions in environmental bacteria.
Antimicrobial group Mechanisms Related natural protein Natural reservoirs
Aminoglycosides AcetylationPhosphorylation Histone-acetylasesProtein kinases Streptomyces
Tetracyclines Efﬂux (mar) Major facilitator superfamily EF-Tu, EF-G Streptomyces
Chloramphenicol AcetylationEfﬂux (mar) AcetylasesMajor facilitatorsuperfamily EF-Tu, EF-G Streptomyces
Macrolides Target mutation 50S ribosomal subunit Streptomyces
β-lactams (methicillin) PBP2a Homologous PBP2a Staphylococcus sciuri
β-lactams (carbapenems) OXA-48 inactivating enzyme Proteins participating in peptidoglycan synthesis Shewanella xiamenensis
OXA-23 inactivating enzyme Proteins participating in peptidoglycan synthesis Acinetobacter radioresistens
Fluoroquinolones Topoisomerase protection Qnr-like protein Shewanella algae
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β-Lactams are the most widely used antibiotics in clinical prac-
tice over the world. Strong selective pressures upon them have
resulted in a continuous increase of resistant isolates (Pitout and
Laupland, 2008). In addition, they have also driven the diversi-
ﬁcation of known β-lactamases genes (Bush and Jacoby, 2010),
in order to increase the spectrum of action, and facilitated the
acquisition of newmechanisms from the environmental resistome,
such as CTX-M β-lactamases (Poirel et al., 2002). Since the 1990s,
the identiﬁcation of new β-lactamase variants has increased dra-
matically (Davies and Davies, 2010), especially as a consequence
of new class A and D β-lactamase variants (Bush and Jacoby,
2010). Moreover, the description of new β-lactamases with car-
bapenemase activity such as NDM and KPC (Klebsiella producing
carbapenemase; Bonomo, 2011; Cornaglia et al., 2011), outbreaks
of known β-lactamases such as OXA-48 (Dimou et al., 2012) and
the spread of ampC in plasmids (D’Andrea et al., 2011) have con-
tributed to the current state of alarm (Bush, 2010). We have
analyzed, for the better understanding of the factors and processes
underlying the recent spread of β-lactamases, the evolutionary
dynamics of three β-lactamase families, i.e., ESBL-OXA, CYM,
and IMP, representing enzymes belonging to classes D, C, and
B, respectively. We decided to exclude the most prevalent (Class
A), such as TEM and CTX-M, because they are well character-
ized (Salverda et al., 2010; Cantón et al., 2012) and their extent
diversity is the consequence of recent evolution in response to the
clinical use of β-lactam antibiotics (Weinreich et al., 2006; Novais
et al., 2010). We have also excluded other worrying cases for pub-
lic health, such as NDM and KPC, because the diversity of their
known variants is still very low for a phylogenetic analysis.
It is already well understood that the OXA family is very
diverse (Sanschagrin et al.,1995) andold (BarlowandHall,2002b).
Only one phylogenetic analysis has been published using 35
OXA β-lactamases (Barlow and Hall, 2002b). The main conclu-
sions of Barlow’s work were: ﬁrst, four branches were identiﬁed
(OXA-1/OXA-9; OXA-2; OXA-5; OXA-23); second, of the three
mobilization events from a chromosomal site to plasmids detected
two were ancestral events (OXA-1); and third, three branches
(OXA-1, OXA-2, and OXA-10) were under signiﬁcant positive
selection at the beginning of the diversiﬁcation process. A total
of 192 ESBL-OXA sequences downloaded from GenBank were
used in our new approach. In order to facilitate the interpreta-
tion of the resulting maximum-likelihood (ML) phylogenetic tree,
highly supported (BS > 95%) clades of closely related sequences
have been grouped (Figure 2). Each group has been denoted
by a representative OXA variant present therein and the result
essentially matches the nomenclature of similar groups in previ-
ous works (Couture et al., 1992; Poirel et al., 2010). Five major
branches can be distinguished now. The new branch identiﬁed
corresponds to OXA-61/63. The OXA-1/OXA-9 branch shows two
different dynamics. The OXA-9 clade differs from other previous
groups in its ancient origin, with long internal branches indicating
long periods of evolution after divergence from the corresponding
ancestors. On the contrary, the OXA-1 clade includes sequences
from several different species such as E. coli,P. aeruginosa,K. pneu-
moniae, and others. They are very similar and suggest a very recent
spread from a common ancestor. The OXA-51/OXA-23 branch
includes 120 sequences, all but one from Acinetobacter. From
these results, it is likely that this group of sequences originated
in Acinetobacter and has remained distributed mostly within this
genus. The only exception corresponds to a plasmid-borne rep-
resentative isolated in Klebsiella, where it probably arrived from
an Acinetobacter ancestor. The OXA-51 clade, the largest sub-
group, is a very homogeneous group of sequences, with an average
nucleotide distance of 0.018 substitutions/site (s/s) and a maxi-
mum within-group distance of 0.036 s/s. These results indicate
that this group has diversiﬁed recently. Similarly, recent diversi-
ﬁcation events were suggested in the OXA-10 (the second largest
group with 18 sequences) and OXA-2 clades. The average pairwise
divergences were 0.022 s/s and 0.132 s/s and a maximum value of
0.045 s/s and 0.288 s/s, respectively. The OXA-54 clade, with very
recently evolved sequences, was also found to be closely related to
the OXA-2 clade.
These results are indicating that only some branches are evolv-
ing quickly and they could be under positive selection. Hence,
the selective processes might have left an imprint in the form
of increased rates of non-synonymous substitutions (dN) com-
pared to those of synonymous substitutions (dS). In consequence,
we have tested this hypothesis by comparing the rates of dS and
dN substitutions at each codon. Based on the ML tree, estimates
of the two substitution rates were obtained using the ancestral
states inferred by ML under a Muse–Gaut model (Muse and
Gaut, 1994) of codon substitution and the Tamura–Nei model
of nucleotide substitution (Tamura and Nei, 1993). Computa-
tion of dN/dS was performed with the Hyphy software package
(Kosakovsky Pond et al., 2005). Positions with <95% sequence
coverage (i.e., with >5% of the sequences presenting a gap) were
removed from the analysis. In contrast to the initial expectation,
no codonpresented a statistically signiﬁcant higher rate of dN than
dS substitutions. The same general results were obtained when the
different groups in the OXA phylogenetic tree were analyzed sepa-
rately in search of positively selected codons aswell as in an analysis
with the seven ungrouped sequences of this gene (Figure 1). This
result indicates that neither the ancient divergence nor the recent
spread of some groups of OXA alleles have been driven primarily
by selection acting at this (codon) level.
Plasmid-encoded ampC genes have been known since 1989
when CMY-1 was described in K. pneumoniae isolates (Bauern-
feind et al., 1989), while the most common plasmid-mediated
AmpC β-lactamaseworldwide is CMY-2 (Jacoby, 2009). Generally,
CMY-2 enzymes are responsible for outbreaks across European
countries (D’Andrea et al., 2011). CMY-1 and CMY-2 have differ-
ent phylogenetic origins (Figure 3A); whereas CMY-1 and related
variants are close to chromosomally determined AmpC enzymes
in Aeromonadaceae, CMY-2 and evolved variants are related to
AmpC from Citrobacter freundii (Barlow and Hall, 2002a). A total
of 32 CMY alleles with known date and country of ﬁrst isola-
tion were included in this analysis. These variants cluster into two
well-deﬁned and distant groups in the reconstructedML tree using
the Tamura-3P + gamma model (Figure 3), denoted CMY-1 and
CMY-2. The CMY-2 group is larger and more diverse. A large
number of sequences (n = 22) from the ﬁve continents are very
similar and have diversiﬁed very recently, while the ﬁve remaining
sequences in the CMY-2 group have a more ancient origin. This
larger group is dominated by isolates from E. coli, but a recent
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FIGURE 2 | Summarized representation of the maximum-likelihood tree
of OXA genes obtained with the K2P + GI model of evolution. Multiple
nucleotide sequence alignments were obtained using the corresponding
amino acid sequences with Muscle (Edgar, 2004a,b). Maximum-likelihood
trees were obtained using the most appropriate model of evolution resulting
from the comparison of Bayesian Information Criterion (BIC) values for 24
alternative models including gamma-distributed heterogeneous rates of
evolution among and invariant sites. Support of the inferred clusters was
evaluated with 1000 bootstrap replicates; BS values >70% are indicated. All
these methods were used as implemented in MEGA 5 (Tamura et al., 2011).
The scale bar corresponds to substitutions/site. The role of natural selection
was investigated at the codon level by analyzing the difference between
dN–dS substitution rates at different positions. Based on the corresponding
maximum likelihood trees using a Muse–Gaut model (Muse and Gaut, 1994)
of codon substitution and theTamura–Nei model of nucleotide substitution
(Tamura and Nei, 1993). Computation of dN/dS was performed with the
Hyphy software package (Kosakovsky Pond et al., 2005). Additionally, two
tests of neutrality were applied to the three data sets: the Fisher’s exact test
of neutrality and a test based on bootstrapping (1000 replicates) of dN–dS
values from which a variance of the corresponding statistic is derived in
order to test the null hypothesis of neutrality (dN = dS). These tests were
performed using MEGA 5 (Tamura et al., 2011).
colonization and spread into Proteus mirabilis can be observed
in sequences isolated from European countries (D’Andrea et al.,
2011)with apossible origin inNorthAfrica (CMY-4 fromTunisia).
The CMY-1 group included only six sequences from Asian–Paciﬁc
countries, which are distributed evenly in two subgroups of very
similar sequences.
The CMY alignment resulted in 376 codons available for selec-
tion analysis. None of them presented signiﬁcant deviations from
the expected dN−dS value under neutrality, although 123 codons
had positive values for this difference. These analyses corre-
sponded to the whole data set of CMY alleles considered but, as
shown above, there are two main, anciently-diverged groups that
have been analyzed separately in search of positive selection. The
phylogeny-based analysis of CMY-1 variants failed to identify any
codon with a signiﬁcant positive difference between dN and dS,
with only seven codons yielding positive values of this parame-
ter none of which reached statistical signiﬁcance. Similar results
were obtained for the CMY-2 group, with average dN–dS values
of −0.362 (range: −10.484 to 1.000, minimum P = 0.444), and
the two pairwise comparison-based tests failing to reveal evidence
for positive selection. Barlow and Hall (2002a) obtained similar
results using a lowernumber of variants. Although adiversiﬁcation
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FIGURE 3 | Maximum-likelihood tree of CMY genes obtained with the
Tamura-3P + G model of evolution. (A)The upper tree corresponds to
CMY-1 group. (B)The lower one to the CMY-2 group of sequences. Multiple
sequence alignments were obtained using the corresponding amino acid
sequences with Muscle (Edgar, 2004a,b). Maximum-likelihood trees were
obtained using the most appropriate model of evolution resulting from the
comparison of Bayesian Information Criterion (BIC) values for 24 alternative
models including gamma-distributed heterogeneous rates of evolution
among and invariant sites. Support of the inferred clusters was
evaluated with 1000 bootstrap replicates, BS values >70% are indicated.
All these methods were used as implemented in MEGA 5 (Tamura et al.,
2011). The scale bar corresponds to substitutions/site. Detection of
positive selection and neutrality tests were performed as described
in Figure 2.
process has occurred in this group, especially in CMY-2, the newly
arisen variants were not subject to positive selection, in contrast
to TEM and CTX-M enzymes. The hydrolytic activities con-
ferred by chromosomal ampC recovered from the pre-antibiotic
era are essentially the same as plasmid-mediated ampC alleles,
probably because they are all resistant to many β-lactam antibi-
otics. Therefore, the plasmid-mediated AmpC enzymes are not
evolving phenotypically because it is not necessary (Barlow and
Hall, 2002a). However, the impact of single-amino acid sub-
stitutions on the evolution of CMY proteins can be observed
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in particular cases. For instance, the G214E change in CMY-2
increases the catalytic efﬁciency against cefotaxime (Endimiani
et al., 2010), suggesting that although the selective pressure occurs
it might be weak.
β-Lactamases with capacity for hydrolyzing carbapenems are
very versatile in their origins and nucleotide sequence. Currently,
almost 30 families of carbapenemases belonging to classes A, D,
and B are known (Widmann et al., 2012), but new families are
being described continuously (Pollini et al., 2012). The spread of
metalo-β-lactamases (MBL), classiﬁed as class B, presents a major
challenge both for treatment of individual patients and for policies
of infection control (Cornaglia et al., 2011), because they confer
resistance to almost all β-lactams, except aztreonam. There are at
least nine different types of MBL, but probably IMP and VIM are
themost prevalent (Fukigai et al., 2007;Van der Bij et al., 2011) and
diversiﬁed1. The dendrogram of VIM enzymes suggests two recent
events of diversiﬁcation involving VIM-1 and VIM-2 (Cornaglia
et al., 2011).
We have analyzed 21 IMP alleles with year and country of
ﬁrst isolation. The ML tree was constructed using the Tamura-
3P model. According to this phylogeny (Figure 4), several closely
related groups of likely recent origin and many other more
anciently diverged sequences can be observed. The two recently
diverged groups includemostly sequences isolated fromEastAsian
countries. A common feature of these recently spread groups is
that they include most alleles isolated in species not belonging to
P. aeruginosa and A. baumannii. The ﬁrst IMP allele, IMP-1, was
isolated in Japan and it is included in a group with three addi-
tional alleles from the same country. Another group related to
this one includes two sequences isolated in Hong Kong and Singa-
pore, respectively. The second recently spread group includes two
sequences from Taiwan and one from Italy and France. In both
groups, the V67F change was selected on three occasions suggest-
ing that this change could be under positive selection. However,
no mutation presented a statistically signiﬁcant, positive deviation
in the dN–dS parameters indicative of positive selection acting in
the IMP phylogeny. Pairwise comparisons also failed to reveal
positive selection as a driving force in the evolution of these alle-
les. The V67F change is highly variable, non-essential for the
protein function but it could have a role in antibiotic recogni-
tion (Widmann et al., 2012). Moreover, in the IMP-1 clade, the
mutation G235S contributes in increasing the hydrolytic activ-
ity against meropenem (Liu et al., 2012), suggesting a process of
selection.
Despite their many differences at the genetic and ecological lev-
els, the three families of β-lactamases present several remarkable
similarities. The three gene families have several anciently diverged
variants along with others that have spread very recently. Most of
these recently diverged groups include very similar sequences with
only a few nucleotide substitutions and usually only one or two
amino acid replacements. This distribution probably results from
a biased screening of variants – only those with at least one amino
acid difference are reported and deposited in the corresponding
databases, which may lead to the false impression that positive
selection is a major factor driving the evolution of these genes.
1http://www.lahey.com
In fact, our analyses in search of positive selection in these gene
families failed to ﬁnd evidence for it after using both phylogeny-
and pairwise-based analysis of dN–dS differences in codons or
the whole gene. In general, most isolates in recently spread OXA-
and IMP-groups are derived from A. baumannii and P. aerugi-
nosa. Over 210 and 120 β-lactamases have been identiﬁed in A.
baumannii and P. aeruginosa, respectively, suggesting that these
species are crucial reservoirs of β-lactam resistance determinants
(Zhao andHu,2010,2012). Although they are ubiquitous innature
also they are frequently isolated in nosocomial and chronic infec-
tions, exposed to a variety of antibiotic regimens, giving rise to
selection and spread of mechanisms of resistance. In this scenario
these results suggest that these species are an excellent shut-
tle of resistance genes between the environment and pathogenic
strains.
UNDERSTANDING THE ADAPTIVE POSSIBILITIES AND THEIR
CONSTRICTIONS TO PREDICT β-LACTAMASE EVOLUTION
The ability of protein to evolve is dependent on tolerance to
change. TEMβ-lactamases can be extremely tolerant to amino acid
substitutions both in the number of affected positions (>200 posi-
tions can change; Salverda et al., 2010) as in number of amino acids
in a particular position (one-third of the positions in TEM can tol-
erate more than ﬁve different amino acids; Deng et al., 2012). The
combination of potential mutations could increase the theoretical
diversity up to astronomically large numbers. However, only 82
polymorphic positions have been described among the 204 TEM
mutants described so far and, strikingly, 85% of the substitutions
are located in only 17 positions.1 Moreover, the most polymorphic
positions show only 3–4 amino acid changes. So, why does not the
sequence plasticity observed in site-directed mutagenesis experi-
ments translate easily in huge diversiﬁcation of evolved proteins
in nature? (Taverna and Goldstein, 2002).
Many researchers have studied the possible genetic constraints
involved in the discrepancy between the potential and the actu-
ally observed biological plasticity of β-lactamases (Camps et al.,
2007). Mutagenesis studies on TEM-1 did not yield TEM vari-
ants more efﬁcient than TEM-1 in hydrolyzing natural β-lactams
such as ampicillin and cephalosporin C, suggesting that during
thousands of years of evolution TEM-1 has become the most
efﬁcient enzyme in conferring the highest MIC values to natural
β-lactams (Deng et al., 2012). The kinetic effect of this evolved
enzyme is the result of a delicate network of hydrogen bonds
contributing to the enzymatic stabilization. Therefore, it is easy
to imagine that any mutation could alter this balance and con-
sequently decrease its efﬁciency. Internal positions (close to the
active center) are less tolerant of substitutions than external ones
because, presumably, they have more interactions and the equilib-
rium is altered easily (Deng et al., 2012). Therefore, the majority of
mutations in internal positions are generally deleterious but they
might also facilitate the acquisition of new functions (Tokuriki
et al., 2008). For instance, mutations such as R164H in TEM-1
(TEM-29), D179N in SHV-1 (SHV-8), or P167T in CTX-M-1
(CTX-M-58) increase the hydrolytic activity against third genera-
tion β-lactam antibiotics (new function), but decrease the speciﬁc
activity of the existing function as a consequence of a loss of sta-
bility (Poirel et al., 2001; Wang et al., 2002). The protein instability
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FIGURE 4 | Maximum-likelihood tree of IMP genes obtained with the
Tamura-3P model of evolution. Multiple sequence alignments were
obtained using the corresponding amino acid sequences with Muscle
(Edgar, 2004a,b). Maximum-likelihood trees were obtained using the most
appropriate model of evolution resulting from the comparison of Bayesian
Information Criterion (BIC) values for 24 alternative models including
gamma-distributed heterogeneous rates of evolution among and invariant
sites. Support of the inferred clusters was evaluated with 1000 bootstrap
replicates, BS values >70% are indicated. All these methods were used as
implemented in MEGA 5 (Tamura et al., 2011). The scale bar corresponds to
substitutions/site. Detection of positive selection and neutrality tests were
performed as described in Figure 2.
observed with some mutations leads to lower levels of correctly-
folded protein and, consequently, to a reduction in enzymatic
activity (Bloom et al., 2005). Therefore, the stability/instability
level of a mutant protein must be proportional to its ﬁtness.
Almost 40% of TEM-1 artiﬁcial mutations cause a partial or
complete reduction in the level of folded protein (Tokuriki and
Tawﬁk, 2009). Hence as mutations accumulate, the likelihood of
declines in protein ﬁtness increases exponentially (Soskine and
Tawﬁk, 2010).
According to the theoretical estimations, those proteins car-
rying, ﬁve mutations on average, with respect to the wild-type
variant, will reduce their ﬁtness in > 80% (Tokuriki and Taw-
ﬁk, 2009) and the accumulation of >10 mutations per gene
would result in non-functionalization of 99% of the mutated
genes (Soskine and Tawﬁk, 2010). However, several TEM-1
variants, such as TEM-121, TEM-162, or TEM-194, carrying
ﬁve or more mutations have been described in nature. The
increased tolerance to changes observed in these enzymes requires
the presence of mutations capable of compensating the loss of
stability due to previous selection of mutations conferring new
functions (Kather et al., 2008). In other words, the evolution
toward new functions must be facilitated by mutations that act
as compensatory mutations of protein stability defects (Brown
et al., 2010).
The best studied example of compensatory mutation is M182T
in TEM enzymes. This mutation has no effect on the catalytic
activity of TEM-1 (Huang and Palzkill, 1997), however the ther-
modynamic stability of TEM-1 is increased by 2.67 kcal/mol in
the presence of this mutation (Wang et al., 2002). Therefore, the
selection of M182T will be favored when previous mutations that
increase the activity against new β-lactams have reduced protein
stability (Camps et al., 2007). For instance, TEM-15 has substi-
tutions E104K:G238S which contribute synergistically to increase
the hydrolytic activity toward extended-spectrum cephalosporins.
These mutations rearrange the active site and, consequently,
destabilize the enzyme (ΔΔG = 2.24 kcal/mol), whereas the
triple mutant, TEM-52, contains the additional substitution
M182T compensating the loss associated with the E104K:G238S
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substitutions (ΔΔG = −1.76 kcal/mol), increasing the activity
against extended-spectrum β-lactams (Wang et al., 2002). Progres-
sively, other compensatory mutations have been described in TEM
enzymes (Brown et al., 2010).
The presence of compensatory mutations is a global phe-
nomenon, also described in other β-lactamases, such as mutations
A77V in CTX-M (Novais et al., 2008), N70S in metallo-β-
lactamase BcII (Tomatis et al., 2008), or L169I in OXA and
ROB-β-lactamases (Poirel et al., 2002; Galán et al., 2003). From
an evolutionary perspective, these point mutations are essential
because the extra stability promotes the evolvability of the protein
(Bloom et al., 2006), but potentially they can also have negative
effects if the excess stability hinders protein turnover (Brown et al.,
2010). Therefore, an equilibrium between evolvability and robust-
ness is essential for the plasticity of proteins, that is, between the
necessity to adapt to new environments and the ability to maintain
a phenotype in the presence of genotypic variations.
The network model establishes strong associations between
particular mutations. For instance, mutation M182T is more fre-
quently associated with mutations related to ESBL phenotypes
(Huang and Palzkill, 1997), whereas N276D is associated with IRT
phenotypes (Abriata et al., 2012), suggesting co-evolutionary pro-
cesses (Guthrie et al., 2011). In other cases, mutation L210P is
co-selected with R244A (Marciano et al., 2008), whereas mutation
E240K is associated with R164H, suggesting different networks
of compensatory mutations depending on the initial mutation
responsible for the ESBL phenotype. These epistatic constric-
tions required for maintaining stability while activity is increased
drastically reduce the number of possible mutational pathways
(Weinreich et al., 2006;Novais et al., 2010). Therefore, initialmuta-
tions drive evolutionary pathways of protein evolution (Salverda
et al., 2011). The genetic reconstruction based on a combina-
torial strategy of ﬁve mutations in TEM-1, which were chosen
for their large joint phenotypic effect, revealed that only 18 of
120 evolutionary trajectories were accessible through Darwinian
selection (Weinreich et al., 2006). Our group, using the CTX-M
enzyme as model, obtained similar results but concluded that
only the simultaneous presence of cefotaxime and ceftazidime
in the environment permitted reaching the highest level of resis-
tance (Novais et al., 2010). These studies of experimental evolution
on β-lactamases show that only a small fraction of all possible
mutational trajectories are accessible to evolution.
These lines of evidence suggest that many combinations of
mutations must be antagonistic. Pleiotropic antagonism has been
used to describe the incompatibility between ESBL and inhibitor-
resistant β-lactamases phenotypes (Cantón et al., 2008; Ripoll
et al., 2011). However, in this case pleiotropic antagonism is
deﬁned as the incompatibility between mutations conferring the
same phenotype. For instance, mutations D240G and P167S
increase the hydrolytic activity of CTX-M enzymes to ceftazidime.
However, the double mutant confers lower MIC values than
both single mutants in every background (Novais et al., 2010).
Similar results were observed between mutations R164S and
G238S in TEM,which show a strong negative interaction (Salverda
et al., 2011). Laboratory-directed protein evolution experiments
revealed that P167S and G238S mutations were more frequently
selected (Barlow and Hall, 2002c; Novais et al., 2008) which are
known to cause the greatest increase in CAZ and CTX resistance
among all known single CTX-M and TEM mutations. However,
there are more clinical isolates carrying the D240G and R164S
mutations in CTX-M and TEM, respectively. This observation is
contradictory to the Darwinian paradigm of evolution, as geno-
types with higher ﬁtness must be favored by selection (“survival
of the ﬁtness”).
At high mutation rates or weak bottlenecks, selection favors
genotypes with larger networks of interactions, whichwill bemore
tolerant (robust) to the impact of deleterious mutations in spite
of lower ﬁtness. This phenomenon is known as “survival of the
ﬂattest” (Codoñer et al., 2006; Archetti, 2009). Depending on the
environmental conditions, selection may favor an organism that
replicates faster (“survival of the ﬁtness”) or is more robust (“sur-
vival of the ﬂattest”), but not both at the same time (Codoñer
et al., 2006). The high connectedness of robust genotypes will be
a guarantee of innovation without drastically losing functional-
ity in the long time scale (Ferrada and Wagner, 2008), whereas a
high evolvability is a guarantee for survival to strong bottlenecks
in a short time but at the cost of losing many interactions and
old functions. In general, β-lactamases carrying D240G or R164S
have accumulated more mutations and the old functions are less
affected than in β-lactamases harboring P167S or G238S muta-
tions in the ﬁrst step. Therefore, D240G or R164S mutations in
CTX-M and TEM enzymes will condition the “survival of the ﬂat-
test”model; whereas P167S or G238S mutations will contribute to
“survival of the ﬁttest.” These results suggest that the ﬁrst muta-
tions not only determine the co-selection of speciﬁc compensatory
mutations but also condition the selection of certain evolution-
ary strategies. Nevertheless, the ﬁrst mutations to be selected will
also depend on the frequency and intensity of changes in the
environment.
Antibiotic resistance is a public health problem and for many
microbiologists and evolutionary researchers a goal to address the
resistance problem has been to predict the selection of antibiotic
resistance to new antibiotic (Martínez et al., 2007). In this situa-
tion, which types of studies are necessary to analyze in more depth
the development of resistance in human bacterial pathogens? For
many years, studies based on serial-passages experiments have
been used as the best model to predict the selection of muta-
tions involved in extending the spectrum of enzymatic activity
(Martínez et al., 2011). However, this approach generally detected
single mutants and, as a consequence of the strong bottlenecks
involved in this experimental design, in most cases only those ﬁt-
ness variants corresponding to the“survival of the ﬁtness” concept
were recovered (Novais et al., 2008; Ripoll et al., 2011). This sim-
ple vision does not predict the selection of complex mutants based
on the “survival of the ﬂattest” concept. Then, the evolvability of
known antibiotic resistance genes was explored by DNA shufﬂing
and error-prone PCR (Orencia et al., 2001). The combination of
both approaches in ﬂuctuating environments could be more real-
istic, because in these cases mutations representing the “survival
of the ﬂattest,” such as R164S, are easily selected (Blázquez et al.,
2000; Barlow andHall, 2002c). Twonew approaches are contribut-
ing to improve our predictive capacity. One of them, deﬁning
the driving forces the selection in a given combination of time
and environment and understanding the possible evolutionary
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trajectories in the diversiﬁcation process (Weinreich et al., 2006;
Novais et al., 2010). Secondly, the implementation of bioinfor-
matics programs such as FoldX (Deng et al., 2012), determining
the ΔΔG of a new mutant and consequently its stability and ﬁt-
ness. The combinatorial approaches between bioinformatics and
in vitro procedures will give rise to a more complete vision on the
complex process of antibiotic resistance evolution.
ACKNOWLEDGMENTS
Juan-Carlos Galán was supported by research grants from Min-
isterio de Sanidad y Consumo (Instituto de Salud Carlos III,
FIS-PI-12/00567) and HEALTH-F3-2011-282004 (EVOTAR) and
HEALTH-F3-2010-241476 (PAR) from European Commission.
Fernando González was supported by project BFU2011-24112
from MINECO (Spanish Government). Rafael Cantón was sup-
ported by national grant (PS09/00825) and LSHMCT-2008-
223031 and FP7-HEALTH-2010-28251 from the EuropeanUnion.
Juan-Carlos Galán and Fernando González-Candelas belong to
CIBERESP, Network for Biomedical Research in Epidemiology
and Public Health (CB06/02/0053). Rafael Cantón also belongs
to REIPI, Spanish Network for Research in Infectious Diseases
(RD12/0015).
REFERENCES
Abriata, L. A., Merijn, L., Salverda,
M., and Tomatis, P. E. (2012).
Sequence-function-stability relation-
ships in proteins from datasets of
functionally annotated variants: the
case of TEM β-lactamases. FEBS Lett.
586, 3330–3335.
Alekshun, M. N., and Levy, S. B. (2007).
Molecular mechanisms of antibacte-
rial multidrug resistance. Cell 128,
1037–1050.
Allen, H. K., Donato, J., Wang, H.
H., Cloud-Hansen, K. A., Davies, J.,
and Handelsman, J. (2010). Call of
the wild: antibiotic resistance genes
in natural environments. Nat. Rev.
Microbiol. 8, 251–259.
Allen, H. K., Moe, L. A., Rodbum-
rer, J., Gaarder, A., and Handelsman,
J. (2009). Functional metagenomics
reveals diverse beta-lactamases in a
remote Alaskan soil. ISME J. 3,
243–251.
Archetti, M. (2009). Survival of the
steepest: hypersensitivity to muta-
tions as an adaptation to soft selec-
tion. J. Evol. Biol. 22, 740–750.
Arifuzzaman, M., Maeda, M., Itoh, A.,
Nishikata, K., Takita, C., Saito, R.,
et al. (2006). Large-scale identiﬁca-
tion of protein–protein interaction of
Escherichia coli K-12. Genome Res. 16,
686–691.
Bagge, N., Schuster, M., Hentzer, M.,
Ciofu, O., Givskov M., Greenberg, E.
P., et al. (2004). Pseudomonas aerug-
inosa bioﬁlms exposed to imipenem
exhibit changes in global gene expres-
sion and beta-lactamase and algi-
nate production. Antimicrob. Agents
Chemother. 48, 1175–1187.
Baquero, F. (2012). Metagenomic epi-
demiology: a public health need for
the control of antimicrobial resis-
tance. Clin. Microbiol. Infect. 18,
67–73
Baquero, F., and Blázquez, J. (1997).
Evolution of antibiotic resistance.
Trends Ecol. Evol. 12, 482–487.
Baquero, F., Martinez, J. L., and Cantón,
R. (2008). Antibiotics and antibiotic
resistance in water environments.
Curr. Opin. Biotechnol. 19, 260–265.
Baquero, F., Alvarez-Ortega, C., and
Martinez, J. L. (2009). Ecology and
evolution of antibiotic resistance.
Environ. Microbiol. Rep. 1, 469–476.
Baquero, M. R., Bouzon, M., Varea,
J., and Moreno, F. (1995). sbmC,
a stationary-phase induced SOS
Escherichia coli gene, whose product
protects cells from the DNA repli-
cation inhibitor microcin B17. Mol.
Microbiol. 18, 301–311.
Barlow, M., and Hall, B. G. (2002a).
Origin and evolution of the AmpC
β-lactamases of Citrobacter freundii.
Antimicrob. Agents Chemother. 46,
1190–1198.
Barlow, M., and Hall, B. G. (2002b).
Phylogenetic analysis shows that the
OXA β-lactamase genes have been on
plasmids for millions of years. J. Mol.
Evol. 55, 314–321.
Barlow, M., and Hall, B. G. (2002c).
Predicting evolutionary potential: in
vitro evolution accurately reproduces
natural evolution of the TEM beta-
lactamase. Genetics 160, 823–832.
Bauernfeind, A., Grimm, H., and
Schweighart, S. A. (1990). New plas-
midic cefotaximase in a clinical iso-
late of Escherichia coli. Infection 18,
294–298.
Bauernfeind, A., Schweighart, S., and
Chong, Y. (1989). Extended broad
spectrum b-lactamase in Klebsiella
pneumoniae including resistance to
cephamycins. Infection 17, 316–321.
Belda-Ferre, P., Alcaraz, L. D., Cabrera-
Rubio, R., Romero, H., Simón-Soro,
A, Pignatelli, M., et al. (2012). The
oral metagenome in health and dis-
ease. ISME J. 6, 46–56.
Benveniste, R., and Davies, J.
(1973). Aminoglycoside anti-
biotic-inactivating enzymes in
actinomycetes similar to those
present in clinical isolates of
antibiotic-resistant bacteria. Proc.
Natl. Acad. Sci. U.S.A. 70, 2276–2280.
Bhullar, K., Waglechner, N., Pawlowski,
A., Koteva, K., Banks, E. D., Johnston,
M. D., et al. (2012). Antibiotic resis-
tance is prevalent in an isolated cave
microbiome. PLoS ONE 7:e34953.
doi: 10.1371/journal.pone.0034953
Blázquez, J., Morosini, M. I., Negri,
M. C., and Baquero, F. (2000).
Selection of naturally occurring
extended-spectrum TEM beta-
lactamase variants by ﬂuctuating
beta-lactam pressure. Antimicrob.
Agents Chemother. 44, 2182–2184.
Bloom, J. D., Labthavikul, S. T., Otey,
C. R., and Arnold, F. H. (2006). Pro-
tein stability promotes evolvability.
Proc. Natl. Acad. Sci. U.S.A. 103,
5869–5874.
Bloom, J. D., Silberg, J. J., Wilke, C.
O., Drummond, D. A., Adami, C.,
and Arnold, F. H. (2005). Thermo-
dynamic prediction of protein neu-
trality. Proc. Natl. Acad. Sci. U.S.A.
102, 606–611.
Bonomo, R. A. (2011). New Delhi
metallo-b-lactamase and multidrug
resistance: a global SOS? Clin. Infect.
Dis. 52, 485–487.
Brown, N. G., Pennington, J. M.,
Huang, W., Ayvaz, T., and Palzkill T.
(2010). Multiple global suppressors
of protein stability defects facilitate
the evolution of extended-spectrum
TEM β-lactamases. J. Mol. Biol. 404,
832–846.
Bush, K. (1997). The evolution of β-
lactamases. Ciba Found. Symp. 207,
152–163.
Bush, K. (2010). Alarming β-lactamase-
mediated resistance in multidrug-
resistant Enterobacteriaceae. Curr.
Opin. Microbiol. 13, 558–564.
Bush, K., and Jacoby, G. A. (2010).
Updated functional classiﬁcation of
β-lactamases. Antimicrob. Agents
Chemother. 54, 969–976.
Camps, M., Herman, A., Loh, E., and
Loeb, L. A. (2007). Genetic con-
straints on protein evolution. Crit.
Rev. Biochem. Mol. Biol. 42, 313–326.
Cantón, R, González-Alba, J. M.,
and Galán, J. C. (2012). CTX-
M enzymes: origin and diffusion.
Front. Microbiol. 3:110. doi: 10.3389/
fmicb.2012.00110
Cantón, R. (2007). “Epidemiology and
evolution of beta-lactactamases,” in
Evolutionary Biology of Bacteria and
Fungal Pathogens, eds F. Baquero, C.
Nombela, G. H. Cassell, and Jose
A. Gutierrez-Fuentes (Washington:
ASM Press), 249–270.
Cantón, R., Akóva, M., Carmeli, Y.,
Giske, C. G., Glupczynski, Y., Gni-
adkowski, M., et al. (2012). Rapid
evolution and spread of carbapene-
mases among Enterobacteriaceae in
Europe. Clin. Microbiol. Infect. 18,
413–431.
Cantón, R., and Coque, T. M. (2006).
The CTX-M beta-lactamase pan-
demic. Curr. Opin. Microbiol. 9,
466–475.
Cantón, R., Morosini, M. I., de la
Maza, O. M., and de la Pedrosa, E. G.
(2008). IRT and CMT b-lactamases
and inhibitor resistance. Clin. Micro-
biol. Infect. Suppl. 1, 53–62.
Chatterji, M., and Nagaraja, V. (2002).
GyrI: a counter-defensive strat-
egy against proteinaceous inhibitors
of DNA gyrase. EMBO Rep. 3,
261–267.
Codoñer, F. M., Daròs, J. A., Solé,
R. V., and Elena, S. F. (2006). The
ﬁttest versus the ﬂattest: experimen-
tal conﬁrmation of the quasispecies
effect with subviral pathogens. PLoS
Pathog. 2:e136. doi: 10.1371/jour-
nal.ppat.0020136
Cornaglia, G., Giamarellou, H., and
Rossolini, G. M. (2011). Metallo-
β-lactamases: a last frontier for β-
lactams? Lancet Infect. Dis. 11,
381–393.
Couture, F., Lachapelle, J., and
Levesque, R. C. (1992). Phylogeny of
LCR-1 and OXA-5 with class A and
class D b-lactamases. Mol. Microbiol.
6, 1693–1705.
D’Andrea, M. M., Literacka, E., Zioga,
A., Giani, T., Baraniak, A., Fiett,
J., et al. (2011). Evolution and
spread of a multidrug-resistant Pro-
teus mirabilis clone with chromo-
somal AmpC-type cephalosporinases
in Europe. Antimicrob. Agents
Chemother. 55, 2735–2742.
D’Costa, V. M., King, C. E., Kalan, L.,
Morar, M., Sung, W. W., Schwarz, C.,
et al. (2011). Antibiotic resistance is
ancient. Nature 477, 457–461.
D’Costa, V. M., McGrann, K. M.,
Hughes, D. W., and Wright, G. D.
Frontiers in Microbiology | Antimicrobials, Resistance and Chemotherapy February 2013 | Volume 4 | Article 9 | 14
“fmicb-04-00009” — 2013/2/7 — 12:09 — page 15 — #15
Galán et al. Exploring the diversity of β-lactamases
(2006). Sampling the antibiotic resis-
tome. Science 311, 374–377.
da Silva, V. L., Cacador, N. C., da
Silva, C. S., Fontes, C. O., García,
G. D., Nicoli, J. R., et al. (2012).
Occurrence of multidrug-resistant
and toxic-metal tolerant enterococci
in fresh feces from urban pigeons
in Brazil. Microbes Environ. 27,
179–185.
Dantas, G., and Sommer, M. O. (2012).
Context matters – the complex inter-
play between resistome genotypes
and resistance phenotypes. Curr.
Opin. Microbiol. 15, 577–582.
Dantas, G., Sommer, M. O., Oluwase-
gun, R. D., and Church, G. M.
(2008). Bacteria subsisting on antibi-
otics. Science 320, 100–103.
Datta, N., and Kontomichalou, P.
(1965). Penicillinase synthesis con-
trolled by infectious R factors
in Enterobacteriaceae. Nature 208,
239–241.
Davies, J. (2007). Microbies have the
last word. A drastic re-evaluation
of antimicrobial treatment is needed
to overcome the treat of antibiotic-
resistant bacteria. EMBO Rep. 8,
616–621.
Davies, J. E. (1997). Origins, acquisi-
tion and dissemination of antibiotic
resistance determinants. Ciba Found.
Symp. 207, 15–27.
Davies, J., and Davies, D. (2010). Ori-
gins and evolution of antibiotic resis-
tance. Microbiol. Mol. Biol. Rev. 74,
417–433.
Deng, Z., Huang, W., Bakkalbasi, E.,
Brown, N. G., Adamski, C. J., Rice,
K., et al. (2012). Deep sequencing
of systematic combinatorial libraries
reveals β-lactamase sequence con-
straints at high resolution. J. Mol.
Biol. 424, 150–167.
Didelot, X., Bowden, R., Wilson, D. J.,
Peto, T. E., and Crook, D. W. (2012).
Transforming clinical microbiology
with bacterial genome sequencing.
Nat. Rev. Genet. 13, 601–612.
Diene, S. M., Merhej, V., Henry,
M., El, F. A., Roux, V., Robert,
C., et al. (2012). The rhizome of
the multidrug-resistant Enterobacter
aerogenes genome reveals how new
“killer bugs” are created because of
a sympatric lifestyle. Mol. Biol. Evol.
doi: 10.1093/molbev/mss236 [Epub
ahead of print].
Dimou, V., Dhanji, H., Pike, R., Liv-
ermore, D. M., and Woodford, N.
(2012). Characterization of Enter-
obacteriaceae producing OXA-48-
like carbapenemases in the UK. J.
Antimicrob. Chemother. 67, 1660–
1665.
Dolejska, M., Frolkova, P., Florek,
M., Jamborova, I., Purgertova, M.,
Kutilova, I., et al. (2011). CTX-M-
15-producing Escherichia coli clone
B2-O25b-ST131 and Klebsiella spp.
isolates in municipal wastewater
treatment plant efﬂuents. J. Antimi-
crob. Chemother. 66, 2784–2790.
Edgar, R. C. (2004a). MUSCLE: a multi-
ple sequence alignment method with
reduced time and space complex-
ity. BMC Bioinformatics 5:113. doi:
10.1186/1471-2105-5-113
Edgar, R. C. (2004b). MUSCLE:
multiple sequence alignment with
high accuracy and high throughput.
Nucleic Acids Res. 32, 1792–1797.
Endimiani, A., Doi, Y., Bethel, C. R.,
Taracila, M., Adams-Haduch, J. M.,
O’Keefe, A., et al. (2010). Enhancing
resistance to cephalosporins in classC
β-lactamases: impact of Gly214Glu in
CMY-2. Biochemistry 49, 1014–1023.
Fajardo, A., Martínez-Martín, N., Mer-
cadillo, M., Galán, J. C., Ghysels,
B., Matthijs, S., et al. (2008). The
neglected intrinsic resistome of bac-
terial pathogens. PLoS ONE 3:e1619.
doi: 10.1371/journal.pone.0001619
Fajardo, A., and Martínez, J. L. (2008).
Antibiotics as signals that trigger spe-
ciﬁc bacterial responses. Curr. Opin.
Microbiol. 11, 161–167.
Ferrada, E., and Wagner, A. (2008).
Protein robustness promotes evolu-
tionary innovations on large evolu-
tionary time-scales. Proc. Biol. Soc.
275, 1595–1602.
Fischbach, M. A. (2009). Antibiotics
from microbes: converging to kill.
Curr. Opin. Microbiol. 12, 520–507.
Forsberg, K. J., Reyes, A., Wang, B., Sell-
eck, E. M., Sommer, M. O., and Dan-
tas, G. (2012). The shared antibiotic
resistome of soil bacteria and human
pathogens. Science 337, 1107–1111.
Fukigai, S., Alba, J., Kimura, S.,
Iida, T., Nishikura, N., Ishii, Y.,
et al. (2007). Nosocomial outbreak
of genetically related IMP-1 β-
lactamase-producing Klebsiella pneu-
moniae in a general hospital in
Japan. Int. J. Antimicrob. Agents 29,
306–310.
Galán, J. C., Morosini, M. I., Baquero,
M. R., Reig, M., and Baquero,
F. (2003). Haemophilus inﬂuenzae
bla(ROB-1) mutations in hyper-
mutagenic ΔampC Escherichia coli
conferring resistance to cefotaxime
and beta-lactamase inhibitors and
increased susceptibility to cefaclor.
Antimicrob. Agents Chemother. 47,
2551–2557.
Gilliver, M. A., Bennett, M., Begon, M.,
Hazel, S. M., and Hart, C. A. (1999).
Antibiotic resistance found in wild
rodents. Nature 401, 233–234.
Guardabassi, L., Christensen, H., Has-
man, H., and Dalsgaard, A. (2004).
Members of the genera Paenibacil-
lus and Rhodococcus harbor genes
homologous to enterococcal gly-
copeptide resistance genes vanA and
vanB. Antimicrob. Agents Chemother.
48, 4915–4918.
Guardabassi, L., Schwarz, S., and Lloyd,
D. H. (2004). Pet animals as reser-
voirs of antimicrobial-resistant bac-
teria. J. Antimicrob. Chemother. 54,
321–332.
Gullberg, E., Cao, S., Berg, O. G., Ilbäck,
C., Sandegren, L., Hughes, D., et al.
(2011). Selection of resistant bacte-
ria at very low antibiotic concentra-
tions. PLoS Pathog. 7:e1002158. doi:
10.1371/journal.ppat.1002158
Guthrie, V. B., Allen, J., Camps, M., and
Karchin, R. (2011). Network mod-
els of TEM β-lactamase mutations
coevolving under antibiotic selec-
tion show modular structure and
anticipate evolutionary trajectories.
PLoS Comput. Biol. 7:e1002184. doi:
10.1371/journal.pcbi.1002184
Handelsman, J. (2004). Metagenomics:
application of genomics to uncul-
tured microorganisms. Microbiol.
Mol. Biol. Rev. 68, 669–685.
Hedges, R. W., and Jacob, A. E. (1974).
Transposition of ampicillin resistance
from RP4 to other replicons. Mol.
Gen. Genet. 132, 31–40.
Heeb, S., Fletcher, M. P., Chhabra,
S. R., Diggle, S. P., Williams, P.,
and Cámara, M. (2011). Quinolones:
from antibiotics to autoinducers.
FEMS Microbiol. Rev. 35, 247–274.
Henderson, T. A., Young, K. D.,
Denome, S. A., and Elf, P. K. (1997).
AmpC and AmpH, proteins related
to the class C beta-lactamases, bind
penicillin and contribute to the nor-
mal morphology of Escherichia coli. J.
Bacteriol. 179, 6112–6121.
Huang, H., Yang, Z. L., Wu, X. M.,
Wang, Y., Liu, Y. J., Luo, H., et al.
(2012). Complete genome sequence
of Acinetobacter baumannii MDR-TJ
and insights into its mechanism of
antibiotic resistance. J. Antimicrob.
Chemother. 67, 2825–2832.
Huang, W., and Palzkill, T. (1997).
A natural polymorphism in β-
lactamase is a global suppressor. Proc.
Natl. Acad. Sci. U.S.A. 94, 8801–8806.
Isozumi, R., Yoshimatsu, K., Yamashiro,
T., Hasebe, F., Nguyen, B. M., Ngo,
T. C., et al. (2012). bla(NDM-1)-
positive Klebsiella pneumoniae from
environment,Vietnam. Emerg. Infect.
Dis. 18, 1383–1385.
Jacobs, C., Huang, L. J., Bartowsky, E.,
Normark, S., and Park, J. T. (1994).
Bacterial cell wall recycling provides
cytosolic muropeptides as effectors
for beta-lactamase induction. EMBO
J. 13, 4684–4694.
Jacoby, G. A. (2009). AmpC β-
lactamases. Clin. Microbiol. Rev. 22,
161–182.
Ji, G., Beavis, R., and Novick, R. P.
(1997). Bacterial interference caused
by autoinducing peptide variants.
Science 276, 2027–2030.
Kather, I., Jakob, R. P., Dobbek, H., and
Schmid, F. X. (2008). Increased fold-
ing stability of TEM-1 β-lactamase by
in vitro selection. J. Mol. Biol. 383,
238–251.
Kempf, M., Rolain, J. M., Diatta, G.,
Azza, S., Samb, B., Mediannikov, O.,
et al. (2012). Carbapenem resistance
andAcinetobacter baumannii in Sene-
gal: the paradigm of a common phe-
nomenon in natural reservoirs. PLoS
ONE 7:e39495. doi: 10.1371/jour-
nal.pone.0039495
Knapp, C. W., Dolﬁng, J., Ehlert, P.
A., and Graham, D. W. (2010). Evi-
dence of increasing antibiotic resis-
tance gene abundances in archived
soils since 1940. Environ. Sci. Technol.
44, 580–587.
Kosakovsky Pond, S. L., Frost, S. D.
W., and Muse, S. V. (2005). HyPhy:
hypothesis testing using phylogenies.
Bioinformatics 21, 676–679.
Lartigue, M. F., Poirel, L., Aubert,
D., and Nordmann, P. (2006). In
vitro analysis of ISEcp1B-mediated
mobilization of naturally occur-
ring beta-lactamase gene blaCTX-
M of Kluyvera ascorbata. Antimi-
crob. Agents Chemother. 50, 1282–
1286.
Leclercq, R., Cantón, R., Brown,
D. F., Giske, C. G., Heisig, P.,
Macgowan, A. P., et al. (2011).
EUCAST expert rules in antimi-
crobial susceptibility testing. Clin.
Microbiol. Infect. doi: 10.1111/j.1469-
0691.2011.03703.x [Epub ahead of
print].
Leclercq, R., Derlot, E., Duval, J.,
and Courvalin, P. (1988). Plasmid-
mediated resistance to vancomycin
and teicoplanin in Enterococcus fae-
cium. N. Engl. J. Med. 319, 157–161.
Li, X. Z., Livermore, D. M., and Nikaido,
H. (1994a). Role of efﬂux pump(s)
in intrinsic resistance of Pseudomonas
aeruginosa: resistance to tetracycline,
chloramphenicol, and norﬂoxacin.
Antimicrob. Agents Chemother. 38,
1732–1741.
Li, X. Z., Ma, D., Livermore, D. M.,
and Nikaido, H. (1994b). Role of
efﬂux pump(s) in intrinsic resistance
of Pseudomonas aeruginosa: active
efﬂux as a contributing factor to beta-
lactam resistance. Antimicrob. Agents
Chemother. 38, 1742–1752.
Linares, J. F., Gustafsson, I., Baquero, F.,
andMartinez, J. L. (2006). Antibiotics
as intermicrobial signaling agents
www.frontiersin.org February 2013 | Volume 4 | Article 9 | 15
“fmicb-04-00009” — 2013/2/7 — 12:09 — page 16 — #16
Galán et al. Exploring the diversity of β-lactamases
instead of weapons. Proc. Natl. Acad.
Sci. U.S.A. 103, 19484–19489.
Literak, I., Dolejska, M., Radimersky, T.,
Klimes, J., Friedman, M., Aarestrup,
F. M., et al. (2010). Antimicrobial-
resistant faecal Escherichia coli in wild
mammals in central Europe: mul-
tiresistant Escherichia coli producing
extended-spectrum beta-lactamases
in wild boars. J. Appl. Microbiol. 108,
1702–1711.
Literak, I., Dolejska, M., Rybarikova, J.,
Cizek, A., Strejckova, P., Vyskocilova,
M., et al. (2009). Highly variable
patterns of antimicrobial resistance
in commensal Escherichia coli iso-
lates from pigs, sympatric rodents,
and ﬂies. Microb. Drug Resist. 15,
229–237.
Liu, E. M., Pegg, K. M., and
Oelschlaeger, P. (2012). The
sequence-activity relationship bet-
ween metallo-β-lactamases IMP-1,
IMP-6, and IMP-25 suggests
an evolutionary adaptation to
meropenem exposure. Antimi-
crob. Agents Chemother. 56, 6403–
6406.
Lloyd, D. H. (2007). Reservoirs of
antimicrobial resistance in pet ani-
mals. Clin. Infect. Dis. 45(Suppl. 2),
S148–S152.
Lupo, A., Coyne, S., and Beren-
donk, T. U. (2012). Origin and
evolution of antibiotic resistance:
the common mechanisms of emer-
gence and spread in water bod-
ies. Front. Microbiol. 3:18. doi:
10.3389/fmicb.2012.00018
Mallon, D. J., Corkill, J. E., Hazel, S.
M., Wilson, J. S., French, N. P., Ben-
nett, M., et al. (2002). Excretion of
vancomycin-resistant enterococci by
wild mammals. Emerg. Infect. Dis. 8,
636–638.
Marciano, D. C., Pennington, J. M.,
Wang, X., Wang, J., Chen, Y.,
Thomas, V. L., et al. (2008). Genetic
and structural characterization of an
L201P global suppressor substitution
in TEM-1 beta-lactamase. J. Mol.
Biol. 384, 151–164.
Marshall, C. G., Broadhead, G., Leskiw,
B. K., and Wright, G. D. (1997).
D-Ala-D-Ala ligases from glycopep-
tide antibiotic-producing organisms
are highly homologous to the entero-
coccal vancomycin-resistance ligases
VanA and VanB. Proc. Natl. Acad. Sci.
U.S.A. 94, 6480–6483.
Marshall, C. G., Lessard, I. A., Park,
I., and Wright, G. D. (1998).
Glycopeptide antibiotic resistance
genes in glycopeptide-producing
organisms. Antimicrob. Agents
Chemother. 42, 2215–2220.
Martínez, J. L. (2012). The antibiotic
resistome: challenge and opportunity
for therapeutic intervention. Future
Med. Chem. 4, 347–359.
Martínez, J. L., Baquero, F., and Ander-
sson, D. I. (2011). Beyond serial
passages: new methods for predicting
the emergence of resistance to novel
antibiotics. Curr. Opin. Pharmacol.
11, 439–445.
Martínez, J. L. (2009). The role of natu-
ral environments in the evolution of
resistance traits in pathogenic bacte-
ria. Proc. Biol. Sci. 276, 2521–2530.
Martínez, J. L. (2008). Antibiotics and
antibiotic resistance genes in natural
environments. Science 321, 365–367.
Martínez, J. L, Baquero, F., and Ander-
sson, D. I. (2007). Predicting antibi-
otic resistance. Nat. Rev. Microbiol. 5,
958–965.
Martínez, J. L., Fajardo, A., Garmen-
dia, L., Hernandez, A., Linares, J. F.,
Martínez-Solano, L., et al. (2009). A
global view of antibiotic resistance.
FEMS Microbiol. Rev. 33, 44–65.
Martiny, A. C., Martiny, J. B.,
Weihe, C., Field, A., and Ellis,
J. C. (2011). Functional metage-
nomics reveals previously unrecog-
nized diversity of antibiotic resistance
genes in gulls. Front. Microbiol. 2:238.
doi: 10.3389/fmicb.2011.00238.
Massova, I., and Mobashery, S. (1998).
Kinship and diversiﬁcation of bacte-
rial penicillin-binding proteins and
beta-lactamases. Antimicrob. Agents
Chemother. 42, 1–17.
Muse, S. V., and Gaut, B. S. (1994).
A likelihood approach for compar-
ing synonymous and nonsynony-
mous nucleotide substitution rates,
with application to the chloroplast
genome. Mol. Biol. Evol. 11, 715–724.
Nessar, R., Cambau, E., Reyrat, J.
M., Murray, A., and Gicquel, B.
(2012). Mycobacterium abscessus: a
new antibiotic nightmare. J. Antimi-
crob. Chemother. 67, 810–818.
Novais, A., Cantón, R., Coque, T. M.,
Moya, A., Baquero, F., and Galán, J.
C. (2008). Mutational events in cefo-
taximase extended-spectrum beta-
lactamases of the CTX-M-1 cluster
involved in ceftazidime resistance.
Antimicrob. Agents Chemother. 52,
2377–2382.
Novais, A., Comas, I., Baquero, F.,
Cantón, R., Coque, T. M., Moya,
A., et al. (2010). Evolutionary tra-
jectories of β-lactamase CTX-M-1
cluster enzymes: predicting antibiotic
resistance. PLoS Pathog. 6:e1000735.
doi: 10.1371/journal.ppat.1000735
Orencia, M. C., Yoon, J. S., Ness, J. E.,
Stemmer, W. P., and Stevens, R. C.
(2001). Predicting the emergence of
antibiotic resistance by directed evo-
lution and structural analysis. Nat.
Struct. Biol. 8, 238–242.
Osbourn, A. (2010). Secondary
metabolic gene clusters: evolutionary
toolkits for chemical innovation.
Trends Genet. 26, 449–457.
Piddock, L. J. (2006). Multidrug-
resistance efﬂux pumps – not just
for resistance. Nat. Rev. Microbiol. 4,
629–636.
Pitout, J. D., and Laupland, K.
B. (2008). Extended-spectrum β-
lactamase-producing Enterobacteri-
aceae: an emerging public-health
concern. Lancet Infect. Dis. 8,
159–166.
Poeta, P., Radhouani, H., Pinto, L.,
Martinho, A., Rego, V., Rodrigues,
R., et al. (2009). Wild boars
as reservoirs of extended-spectrum
beta-lactamase (ESBL) producing
Escherichia coli of different phyloge-
netic groups. J. Basic Microbiol. 49,
584–588.
Poirel, L., Bercot, B., Millemann,
Y., Bonnin, R. A., Pannaux,
G., and Nordmann, P. (2012).
Carbapenemase-producing Acineto-
bacter spp. in cattle, France. Emerg.
Infect. Dis. 18, 523–525.
Poirel, L., Decousser, J. W., and Nord-
mann, P. (2003). Insertion sequence
ISEcp1B is involved in expression and
mobilization of a bla(CTX-M) beta-
lactamase gene. Antimicrob. Agents
Chemother. 47, 2938–2945.
Poirel, L., Gerome, P., De Champs,
C., Stephanazzi, J., Naas, T., and
Nordmann, P. (2002). Integron-
located oxa-32 gene cassette encod-
ing an extended-spectrum variant of
OXA-2 beta-lactamase from Pseu-
domonas aeruginosa. Antimicrob.
Agents Chemother. 46, 566–569.
Poirel, L., Héritier, C., and Nordmann,
P. (2005). Genetic and biochemical
characterization of the chromosome-
encoded class B beta-lactamases from
Shewanella livingstonensis (SLB-1)
and Shewanella frigidimarina (SFB-
1). J. Antimicrob. Chemother. 55,
680–685.
Poirel, L., Kampfer, P., and Nordmann,
P. (2002). Chromosome-encoded
Ambler class A beta-lactamase of
Kluyvera georgiana, a probable pro-
genitor of a subgroup of CTX-
M extended-spectrum β-lactamases.
Antimicrob. Agents Chemother. 46,
4038–4040.
Poirel, L., Nass, T., and Nordmann,
P. (2010). Diversity, epidemiology
and genetics of class D β-lactamases.
Antimicrob. Agents Chemother. 54,
24–38.
Poirel, L., Potron, A., and Nordmann,
P. (2012). OXA-48-like carbapen-
emases: the phantom menace. J.
Antimicrob. Chemother. 67, 1597–
1606.
Poirel, L., Rodriguez-Martinez, J. M.,
Mammeri, H., Liard, A., and
Nordmann, P. (2005). Origin of
plasmid-mediated quinolone resis-
tance determinant QnrA. Antimicrob.
Agents Chemother. 49, 3523–3525.
Poirel, L., Naas, T., Le Thomas,
I., Karim, A., Bingen, E., and
Nordmann, P. (2001). CTX-M-type
extended-spectrum β-lactamase that
hydrolyzes ceftazidime through a
single amino acid substitution in
the omega loop. Antimicrob. Agents
Chemother. 45, 3355–3361.
Pollini, S., Maradei, S., Pecile, P.,
Olivo, G., Luzzaro, F., Docquier,
J. D., et al. (2012). FIM-1, a new
acquired metallo-β-lactamase from a
Pseudomonas aeruginosa clinical iso-
late from Italy. Antimicrob. Agents
Chemother. 57, 410–416.
Potron, A., Poirel, L., and Nordmann,
P. (2011). Origin of OXA-181, an
emerging carbapenem-hydrolyzing
oxacillinase, as a chromosomal gene
in Shewanella xiamenensis. Antimi-
crob. Agents Chemother. 55, 4405–
4407.
Radimersky, T., Frolkova, P., Janos-
zowska, D., Dolejska, M., Svec,
P., Roubalova, E., et al. (2010).
Antibiotic resistance in faecal bacteria
(Escherichia coli,Enterococcus spp.) in
feral pigeons. J. Appl. Microbiol. 109,
1687–1695.
Ripoll, A., Baquero, F., Novais, A.,
Rodríguez-Domínguez, M. J., Tur-
rientes, M. C., Cantón, R., et al.
(2011). In vitro selection of vari-
ants resistant to beta-lactams plus
β-lactamase inhibitors in CTX-M
beta-lactamases: predicting the in
vivo scenario? Antimicrob. Agents
Chemother. 55, 4530–4536.
Rodriguez-Martinez, J. M., Conejo, M.
C., Martínez-Martínez, L., Cano, M.
E., Velasco, C, and Pascual, A. (2005).
Evaluation of antimicrobial suscepti-
bility of bacteria containing the qnr
gene and FOX-5 beta-lactamase by
four automated systems. Clin. Micro-
biol. Infect. 11, 402–404.
Rodriguez-Martinez, J. M., Poirel, L.,
Cantón, R., and Nordmann, P.
(2006). Common region CR1 for
expression of antibiotic resistance
genes. Antimicrob. Agents Chemother.
50, 2544–2546.
Rolain, J. M., Cantón, R., and Cor-
naglia, G. (2012). Emergence of
antibiotic resistance: need for a new
paradigm. Clin. Microbiol. Infect. 18,
615–616.
Rolain, J. M., Parola, P., and Cornaglia,
G. (2010). New Delhi metallo-beta-
lactamase (NDM-1): towards a new
pandemia? Clin. Microbiol. Infect. 16,
1699–1701.
Frontiers in Microbiology | Antimicrobials, Resistance and Chemotherapy February 2013 | Volume 4 | Article 9 | 16
“fmicb-04-00009” — 2013/2/7 — 12:09 — page 17 — #17
Galán et al. Exploring the diversity of β-lactamases
Romero, D., Traxler, M. F., López, D.,
and Kolter, R. (2011). Antibiotics as
signal molecules. Chem. Rev. 111,
5492–5505.
Salmond, G. P., and Welch, M. (2008).
Antibiotic resistance: adaptive evolu-
tion. Lancet 372, S97–S103.
Salverda, M. L. M., Dellus, E., Gorter,
F. A., Debets, A. J. M., Van der
Oost, J., Hoekstra, R. F., et al.
(2011). Initial mutations direct alter-
native pathways of protein evolu-
tion. PLoS Genet. 7:e1001321. doi:
10.1371/journal.pgen.1001321
Salverda, M. L., De Visser, J. A. G., and
Barlow, M. (2010). Natural evolution
of TEM-1 β-lactamase: experimental
reconstruction and clinical relevance.
FEMS Microbiol. Rev. 34, 1015–1036.
Sanschagrin, F., Couture, F., and
Levesque, R. C. (1995). Pri-
mary structure of OXA-3 and phy-
logeny of oxacillin-hydrolyzing class
D β-lactamases. Antimicrob. Agents
Chemother. 39, 887–893.
Sarkar, S. K., Dutta, M., Chowdhury, C.,
Kumar, A., and Ghosh, A. S. (2011).
PBP5, PBP6 and DacD play different
roles in intrinsic β-lactam resistance
of Escherichia coli. Microbiology 157,
2702–2707.
Schmieder, R., and Edwards, R. (2012).
Insights into antibiotic resistance
through metagenomic approaches.
Future Microbiol. 7, 73–89.
Shahid, M., Khan, F., Shah, M. S.,
Shukla, I., Shujatullah, F., Khan,
H. M., et al. (2012). NDM-1 in
the Indian environment: hitherto the
problem is not disquieting. Asian Pac.
J. Trop. Med. 5, 335–336.
Soskine, M., and Tawﬁk, D. S. (2010).
Mutational effects and the evolution
of new protein functions. Nat. Rev.
Genet. 11, 572–582.
Tamae, C., Liu, A., Kim, K., Sitz, D.,
Hong, J., Becket, E., et al. (2008).
Determination of antibiotic hyper-
sensitivity among 4,000 single-gene-
knockout mutants of Escherichia coli.
J. Bacteriol. 190, 5981–5988.
Tamura, K., and Nei, M. (1993). Esti-
mation of the number of nucleotide
substitutions in the control region of
mitochondrial DNA in humans and
chimpanzees. Mol. Biol. Evol. 10,
512–526.
Tamura, K., Peterson, D., Peterson,
N., Stecher, G., Nei, M., and
Kumar, S. (2011). MEGA5:molecular
evolutionary genetics analysis using
maximum likelihood, evolutionary
distance, and maximum parsimony
methods. Mol. Biol. Evol. 28, 2731–
2739.
Tanaka, Y., Nishida, K., Nakamura, T.,
Chapagain, S. K., Inoue, D., Sei,
K., et al. (2012). Characterization of
microbial communities distributed
in the groundwater pumped from
deep tube wells in the Kathmandu
Valley of Nepal. J. Water Health 10,
170–180.
Tausova, D., Dolejska, M., Cizek, A.,
Hanusova, L., Hrusakova, J., Svo-
boda,O., et al. (2012). Escherichia coli
with extended-spectrum β-lactamase
and plasmid-mediated quinolone
resistance genes in great cormorants
and mallards in Central Europe. J.
Antimicrob. Chemother. 67, 1103–
1107.
Taverna, D. M., and Goldstein, R. A.
(2002). Why are proteins so robust
to site mutations? J. Mol. Biol. 315,
479–484.
Tokuriki, N., and Tawﬁk, D. S. (2009).
Stability effects of mutations andpro-
tein evolvability. Curr. Opin. Struct.
Biol. 19, 596–604.
Tokuriki, N., Stricher, F., Serrano, L.,
and Tawﬁk, D. S. (2008). How pro-
tein stability and new functions trade
off. PLoS Comput. Biol. 4:e1000002.
doi: 10.1371/journal.pcbi.1000002
Toleman, M. A., Spencer, J., Jones, L.,
and Walsh, T. R. (2012). blaNDM-
1 is a chimera likely constructed
in Acinetobacter baumannii. Antimi-
crob. Agents Chemother. 56, 2773–
2776
Tomatis, P. E., Fabiane, S.M., Simona, F.,
Carloni, P., Sutton, B. J., and Vila, A.
J. (2008). Adaptive protein evolution
grants organismal ﬁtness by improv-
ing catalysis and ﬂexibility. Proc.
Natl. Acad. Sci. U.S.A. 105, 20605–
20610.
Torres-Cortés, G., Millán, V., Ramírez-
Saad, H. C., Nisa-Martínez, R.,
Toro, N., and Martínez-Abarca, F.
(2011). Characterization of novel
antibiotic resistance genes identi-
ﬁed by functional metagenomics on
soil samples. Environ. Microbiol. 13,
1101–1114.
Van der Bij, A. K., Van Mans-
feld, R., Peirano, G., Goessens,
W. H. F., Severin, J. A., Pitout,
J. D. D., et al. (2011). First out-
break ofVIM-2metallo-β-lactamase-
producing Pseudomonas aeruginosa
in The Netherlands: microbiol-
ogy, epidemiology and clinical out-
comes. Int. J. Antimicrob. Agents 37,
513–518.
Walsh, T. R. (2008). Clinically sig-
niﬁcant carbapenemases: an update.
Curr. Opin. Infect. Dis. 21, 367–371.
Walsh, T. R.,Weeks, J., Livermore,D.M.,
and Toleman, M. A. (2011). Dissem-
ination of NDM-1 positive bacteria
in the New Delhi environment and
its implications for human health:
an environmental point prevalence
study. Lancet Infect. Dis. 11,
355–362.
Wang, X., Minasov, G., and Shoichet,
B. K. (2002). Evolution of an antibi-
otic resistance constrained by stabil-
ity and activity trade-offs. J. Mol. Biol.
320, 85–95.
Weinreich, D. M., Delaney, N. F.,
Depristo, M. A., and Hartl, D.
L. (2006). Darwinian evolution can
follow only very few mutational
paths to ﬁtter proteins. Science 312,
111–114.
Widmann, M., Pleiss, J., and
Oelschlaeger, P. (2012). Systematic
analysis of metallo-β-lactamases
using an automated database.
Antimicrob. Agents Chemother. 56,
3481–3491.
Wright, G. D. (2007). The antibiotic
resistome: the nexus of chemical and
genetic diversity. Nat. Rev. Microbiol.
5, 175–186.
Wright, G. D. (2010). Antibiotic resis-
tance in the environment: a link to
the clinic? Curr. Opin. Microbiol. 13,
589–594.
Wright, G. D. (2010). The antibiotic
resistome. Expert Opin. Drug Discov.
5, 779–788.
Yim, G., Wang, H. H., and Davies,
J. (2007). Antibiotics as signalling
molecules. Philos. Trans. R. Soc. Lond.
B Biol. Sci. 362, 1195–1200.
Yong, D., Toleman, M. A., Giske,
C. G., Cho, H. S., Sundman, K.,
Lee, K., et al. (2009). Characteriza-
tion of a new metallo-beta-lactamase
gene, bla(NDM-1), and a novel ery-
thromycin esterase gene carried on a
unique genetic structure in Klebsiella
pneumoniae sequence type 14 from
India. Antimicrob. Agents Chemother.
53, 5046–5054.
Zhang, X. X., Zhang, T., and Fang,H. H.
(2009). Antibiotic resistance genes in
water environment. Appl. Microbiol.
Biotechnol. 82, 397–414.
Zhao, W. H., and Hu, Z. Q. (2012).
Epidemiology and genetics of CTX-
M extended-spectrum β-lactamases
in Gram-negative bacteria. Crit. Rev.
Microbiol. 39, 79–101.
Zhao, W. H., and Hu, Z. Q. (2010).
β-lactamases identiﬁed in clini-
cal isolates of Pseudomonas aerug-
inosa. Crit. Rev. Microbiol. 36,
245–258.
Conflict of Interest Statement: The
authors declare that the research was
conducted in the absence of any com-
mercial or ﬁnancial relationships that
could be construed as a potential con-
ﬂict of interest.
Received: 15 December 2012; accepted:
09 January 2013; published online: 08
February 2013.
Citation: Galán J-C, González-Candelas
F, Rolain J-M and Cantón R (2013)
Antibiotics as selectors and accelerators of
diversity in the mechanisms of resistance:
from the resistome to genetic plasticity in
the β-lactamases world. Front. Microbio.
4:9. doi: 10.3389/fmicb.2013.00009
This article was submitted to Fron-
tiers in Antimicrobials, Resistance and
Chemotherapy, a specialty of Frontiers in
Microbiology.
Copyright © 2013 Galán, González-
Candelas, Rolain and Cantón. This is
an open-access article distributed under
the terms of the Creative Commons
Attribution License, which permits use,
distribution and reproduction in other
forums, provided the original authors and
source are credited and subject to any
copyright notices concerning any third-
party graphics etc.
www.frontiersin.org February 2013 | Volume 4 | Article 9 | 17
